US 12,599,433 B2Grant
Apparatus and method for intra-cardiac mapping and ablation
Issue Date:2026-04-14
•35 Claims
•9 Drawing Sheets
Abstract
An intra-cardiac mapping system is based on locating the ports through which blood flows in or out the heart chambers. For many procedures, such as ablation to cure atrial fibrillation, locating the pulmonary veins and the mitral valve accurately allows to perform a Maze procedure. The location of the ports and valves is based on using the convective cooling effect of the blood flow. The mapping can be performed by a catheter-deployed expandable net or a scanning catheter. The same net or catheter can also perform the ablation procedure.
Metadata
Assignee
- KARDIUM INC.
Inventors
- Daniel Gelbart
- Samuel Victor Lichtenstein
Application Information
Application Number:US 17/513,070
Filing Date:2021-10-28
Priority Date:2006-06-28
Art Unit:3794
Classifications
IPC:
A61B18/14A61B5/00A61B5/01A61B5/0205A61B5/027A61B5/028A61B18/00A61B18/02A61B18/08A61B18/10A61B18/12A61B18/18A61B18/20A61B34/00A61B34/10A61B90/00
Field of Search:
A51B 5/015A51B 5/1076A51B 5/1077A51B 5/14503A51B 5/1491A51B 5/4887A51B 5/6858A51B 5/6869A61B 2018/0016A61B 2018/00267A61B 2018/00351A61B 2018/00375A61B 2018/00791A61B 2018/00815A61B 2018/00821A61B 2018/00904
Patent Drawings (9 sheets)
Description
Cross-Reference to Related Applications
[0001] This application is a continuation of prior U.S. patent application Ser. No. 16/381,344, filed Apr. 11, 2019, now U.S. Pat. No. 11,399,890, issued on Aug. 2, 2022, which is a continuation of prior U.S. patent application Ser. No. 15/697,744, filed Sep. 7, 2017, now U.S. Pat. No. 10,828,093 issued on Nov. 10, 2020, which is a continuation of prior U.S. patent application Ser. No. 14/804,810, filed Jul. 21, 2015, now U.S. Pat. No. 9,987,083 issued on Jun. 5, 2018, which is a continuation of prior U.S. patent application Ser. No. 13/785,931, filed Mar. 5, 2013, now U.S. Pat. No. 9,119,633, issued on Sep. 1, 2015, which is a continuation-in-part of prior U.S. patent application Ser. No. 11/475,950, filed Jun. 28, 2006, now U.S. Pat. No. 8,920,411, issued on Dec. 30, 2014, the entire disclosure of each of these applications is hereby incorporated herein by reference.
Technical Field
[0002] This disclosure generally relates to minimally invasive heart surgery, also known as percutaneous cardiac surgery and particularly relates to percutaneous mapping and ablation.
Background
[0003] Atrial fibrillation is a well known disorder in which spurious electrical signals cause an irregular heart beat. The disorder has a well known cure known as the Maze procedure, in which a border is ablated around the sources of the spurious signals, typically in the left atrium but sometimes in the right atrium. The procedure is very commonly performed under direct vision, but difficult to perform percutaneously via a catheter because of the associated risk. Any error in navigation inside the heart can cause fatal damage. The key to a percutaneous procedure is mapping of the inside of the right and left atrium. Access to the right atrium is simple via the superior vena cava; the left atrium can be reached i) by perforating the transatrial septum, ii) via the aorta and the left ventricle or iii) via the pulmonary veins.
[0004] Prior approaches to map the inside of the atrium relied on electrical activity picked up from the atrium wall. These approaches require intimate electrical contact, not always possible because of scar tissue and deposits. These approaches may fail to accurately map the edges of the openings where the veins enter the atrium; information that is useful for correct placement of the ablation pattern. Other mapping methods, such as using an array of ultrasonic transducers, are not practical since such arrays typically will not fit through a catheter of a reasonable size (8-10 mm diameter). A superior mapping apparatus and method, that enables safe execution of the Maze and other intra-cardiac procedures is desirable.
[0005] A good survey article on the subject is: “Ablation of Atrial Fibrillation: Energy Sources and Navigation Tools: A survey” by Ruediger Becker and Wolfgang Schoels (J. of Electrocardiology, Vol 37, 2004, pp 55-61). The article includes an extensive bibliography.
Summary
[0006] Embodiments of an intra-cardiac mapping system are based on locating openings or ports and values through which blood flows in or out of the heart chambers. For many procedures, such as ablation to cure atrial fibrillation, accurately locating the pulmonary veins and the mitral valve allows performance of a Maze procedure. The openings, ports and valves may be located based on the convective cooling effect of the blood flow. The mapping can be performed by a catheter-deployed expandable net or a scanning catheter. The same net or catheter can also perform the ablation procedure.
[0007] In one embodiment, a method for intra-cardiac mapping comprises: introducing a plurality of flow sensors into an intra-cardiac cavity: locating points in a wall forming said cavity based on sensing blood flow; and mapping said walls of said cavity based on said points. The method for intra-cardiac mapping may include said blood flow being sensed by its convective cooling effect on a heated sensor. The method for intra-cardiac mapping may include said sensing being done by a steerable linear array. The method for intra-cardiac mapping may include said mapping being used for treating atrial fibrillation by RF ablation. The method for intra-cardiac mapping may include being used for treating atrial fibrillation by microwave ablation. The method for intra-cardiac mapping may include said mapping being used for treating atrial fibrillation by cryogenic ablation. The method for intra-cardiac mapping may include said mapping being used for treating atrial fibrillation by laser ablation. The method for intra-cardiac mapping may include said blood flow being sensed by the resistance change of a heated resistive wire.
[0008] In another embodiment, a method for intra-cardiac mapping comprises: introducing an expandable sensing mesh into said cavity via a catheter; using said mesh to locate openings in walls forming said cavity based on the convective heat transfer of blood flowing through said holes; and mapping inside of said cavity based on location of said openings. The method for intra-cardiac mapping may include said blood flow being sensed by its convective cooling effect on a heated sensor. The method for intra-cardiac mapping may include said sensing being done by a steerable linear array. The method for intra-cardiac mapping may include said mapping being used for treating atrial fibrillation by RF ablation. The method for intra-cardiac mapping may include said mapping being used for treating atrial fibrillation by microwave ablation. The method for intra-cardiac mapping may include said mapping being used for treating atrial fibrillation by cryogenic ablation. The method for intra-cardiac mapping may include said mapping being used for treating atrial fibrillation by laser ablation. The method for intra-cardiac mapping may include said blood flow being sensed by the resistance change of a heated resistive wire. The method for intra-cardiac mapping may include said mesh comprising small coils of nickel wire wound on a mesh of a flexible insulator. The method for intra-cardiac mapping may include an electronic switch used to minimize the number of electrical wires passing through said catheter.
[0009] In yet another embodiment, a method for treating atrial fibrillation comprises: introducing at least one flow sensor into an intra-cardiac cavity; locating points in a wall forming said cavity based on sensing blood flow; mapping walls of said cavity based on said points; and ablating a pattern into walls of said cavity based on said mapping. The method for treating atrial fibrillation may include said blood flow being sensed by its convective cooling effect on a heated sensor. The method for treating atrial fibrillation may include said sensing being done by a steerable linear array. The method for treating atrial fibrillation may include said mapping being used for treating atrial fibrillation by RF ablation. The method for treating atrial fibrillation may include said mapping being used for treating atrial fibrillation by microwave ablation. The method for treating atrial fibrillation may include said mapping being used for treating atrial fibrillation by cryogenic ablation. The method for treating atrial fibrillation may include said mapping being used for treating atrial fibrillation by laser ablation. The method for treating atrial fibrillation may include said blood flow being sensed by the resistance change of a heated resistive wire. The method for treating atrial fibrillation may include said flow sensors also acting as electrodes for said ablation. The method for treating atrial fibrillation may include said flow sensor being based on temperature sensing and a same sensor being used to monitor temperature during said ablation. The method for treating atrial fibrillation may include said ablation being unipolar. The method for treating atrial fibrillation may include said ablation being bipolar. The method for treating atrial fibrillation may include said ablated pattern being a Maze procedure.
Brief Description of the Drawings
[0010] In the drawings, identical reference numbers identify similar elements or acts. It is to be understood that the attached drawings are for purposes of illustrating the concepts of the invention and may not be to scale. For example, the sizes, relative positions, shapes, and angles of or associated with elements in the drawings are not necessarily drawn to scale, and some elements may be arbitrarily enlarged and positioned to improve drawing legibility. Further, the particular shapes of the elements as drawn may differ from their actual shapes and, in this regard, may be selected instead of the respective actual shapes for ease of recognition in the drawings.
[0011] FIG. 1 is a cross sectional view of the heart showing the mapping mesh deployed in the left atrium.
[0012] FIG. 2 is a cross sectional view of the sensing device.
[0013] FIGS. 3A and 3B are isometric views of the mesh in both folded and expanded position.
[0014] FIG. 4 is an isometric enlarged view of a portion of the mesh.
[0015] FIG. 5 is an electrical schematic of a mapping and ablation system.
[0016] FIG. 6 is an electrical schematic of a simplified mapping system.
[0017] FIG. 7 is a schematic view of the display console of the system.
[0018] FIGS. 8A and 8B are graphical views of a mapping that illustrate an interpolation principle.
[0019] FIG. 9 is a cross sectional view of an alternate embodiment, using mechanical or manual scanning in one axis.
[0020] FIG. 10 is a cross sectional view of an alternate embodiment, using mechanical scanning in two dimensions.
[0021] FIG. 11 shows the use of the invention for bipolar ablation.
Detailed Description
[0022] In the following description, certain specific details are set forth in order to provide a thorough understanding of various disclosed embodiments. However, one skilled in the relevant art will recognize that embodiments may be practiced without one or more of these specific details, or with other methods, components, materials, etc. In other instances, well-known structures associated with apparatuses and methods for intra-cardiac mapping and ablation have not been shown or described in detail to avoid unnecessarily obscuring descriptions of the embodiments.
[0023] Unless the context requires otherwise, throughout the specification and claims which follow, the word “comprise” and variations thereof, such as, “comprises” and “comprising” are to be construed in an open, inclusive sense, that is as “including, but not limited to.”
[0024] Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, the appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
[0025] As used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the content clearly dictates otherwise. It should also be noted that the term “or” is generally employed in its non-exclusive sense including “and/or” unless the content clearly dictates otherwise.
[0026] The headings and Abstract of the Disclosure provided herein are for convenience only and do not interpret the scope or meaning of the embodiments.
[0027] FIG. 1 shows a sensing and ablation mesh 7 inserted into a left atrium 3 of a heart 1 according to one illustrated embodiment.
[0028] By way of example, the mesh 7 may be delivered via a catheter 60 inserted via a superior vena cava 4 and penetrating a transatrial septum from a right atrium 2 of the heart 1. The mesh 7 is communicatively coupled to the rest of the system, for example, by electrical wires 6.
[0029] Before any ablation takes place, the inside of the left atrium 3 is mapped in order to locate the openings or ports 8 leading to the pulmonary veins 5, as well as the mitral valve 9. A typical Maze procedure ablates a “fence” around openings or ports 8 to stop propagation of spurious electrical signals which cause the heart 1 to contract at the wrong times.
[0030] The mapping may locate some or all of the openings or ports 8 through which blood flows in and out of the left atrium 3, as the Maze procedure is mainly concerned with the location of these openings or ports 8. By the way of example, in the left atrium 3, the four openings or ports 8 leading to the pulmonary veins 5 as well as the mitral valve 9 may be located. The location of these openings or ports 8 may be based on the fact that the convective cooling effect of the blood is significant, and a slightly heated mesh 7 pressed against the walls of the left and/or right atrium 3, 2 will be cooler at the areas which are spanning the openings or ports 8 carrying blood.
[0031] FIG. 2 shows the ablation mesh 7 covered by miniature heating and/or temperature sensing elements 10a-10c flow (collectively 10, only three illustrated in the figure). Each one of these elements 10a-10c comprises a few turns of a resistive wire, for example nickel wire, wound on an electrically insulated mesh. A low current is passed through each element 10, raising a temperature of the element 10 by about 1 degree C. above normal blood temperature. A first element 10b, which lies across an opening or port 8 of one of the pulmonary veins 5, will be cooled by blood flow. The other elements are against a wall 3 and hence do not lie across any of the openings or ports 8.
[0032] By identifying the relatively cooler elements 10a, 10c on the mesh 7, the location of the openings or ports 8 may be found.
[0033] This method does not require intimate contact with the wall 3, as the cooling effect is significant even a few millimeters away from the opening.
[0034] The same elements 10 can be used as ablation electrodes during an ablation stage. It was found that the power required to raise the temperature of the mesh 7 by a small but easily detectable amount is very small, on the order of 10-50 mW per element 10. If the elements 10 are made of a material that has a significant change in resistance with temperature, the temperature drop can be sensed by measuring a voltage across the element 10 when driven by a constant current. A good choice for element material is nickel wire, which is inert, highly resistive and has a significant temperature coefficient of resistance (about 0.6% per deg C.). Since the resistance of the elements 10 is low (typically 0.1-1 ohm), the electrical noise is very low and temperature changes as low as 0.1 deg can be easily detected. For even higher detection sensitivity, the voltage waveform can be sampled in synchronization with the heart rate or the average voltage removed and only the change amplified. Such methods are referred to as “AC coupling”. A further refinement to reduce the electrical noise is to pass the signal through a digital band pass filter having a center frequency tracking the heart rate. To avoid any potential tissue damage, the temperature of the elements 10 of the mesh 7 is only slightly above the blood temperature, typically 0.1-3 degrees C. above blood temperature.
[0035] FIG. 3A shows the mesh 7 in a compressed configuration “A” and FIG. 3B shows the mesh 7 in an expanded configuration “B”. Since the mesh 7 has to fit into a catheter 60, the mesh 7 should be very flexible. Besides elements 10 discussed earlier, there is also a large number of leads 13 coming out of the mesh 7. Leads 13 can be loose, as shown in FIG. 3B , or may be bonded to the mesh 7. To avoid feeding a large number of wires all the way to an operating console, an electronic selector switch may be employed, which may, for example, be mounted in the catheter 60. This reduces the number of electrical wires from over 100 to about 10. The mesh 7 can be self-expanding (elastic) or balloon-expandable. Self expanding allows normal blood flow during the procedure. For balloon expandable devices, the expansion balloon should be removed before the mapping, to avoid blocking the flow of blood.
[0036] FIG. 4 shows the mesh 7 in more detail. Insulated longitudinal (i.e., parallel to catheter) wires 25 are crossed by cross wires 26. Each section of the mesh 7 is covered by a few turns of thin (0.05-0.2 mm) nickel wire 10 having leads 13. The leads 13 can be regular thin copper wire. The longitudinal wires 25 can be stiffer than the cross wires 26, therefore can be made self-expanding by incorporating a core 14 made of coiled flexible metal wire such as Nitinol. A metallic core may interfere with the ablation process at higher frequencies and can be replaced by simply making the longitudinal wires 25 of a polymeric material thicker than the cross wires 26. The cross wires 26, which may form rings around wires 25, should be very flexible to compress into the catheter 60. The cross wires 26 could incorporate a very thin wire or coiled up wire. Use of a flexible mesh 7 not only allows percutaneous delivery, but also permits the mesh 7 to follow the atrial volume change each heartbeat. The mesh 7 should stay in contact with or close to the atrial wall during the cardiac cycle, otherwise the measurement and the ablation may only be performed during parts of the cardiac cycle. The diameter of the longitudinal wires 25 and cross wires 26 are typically 0.2-1 mm. The mesh 7 may include about 10-20 longitudinal wires 25 and about 10-20 cross wires 26. The insulation can be any polymeric material such as thin enamel or polymer coating. Practically any polymer can be used, as the maximum temperature it will be subject to, including during the ablation phase, is around 100 degrees C.
[0037] FIG. 5 shows an electrical system, according to one illustrated embodiment. The elements 10 may be resistive heaters wound on the mesh 7. Each of the elements 10 is connected by electronic element switches 15 (typically FET or MOS-FET type) to a single pair of wires leading out of the body to a mode selection switch 17. Element switches 15 are selected by de-multiplexer or selector 16. The de-multiplexer or selector 16 is controlled by a small number of wires or even a single wire if data is sent in serial form, by a multiplexer 22. Element switches 15 and de-multiplexer or selector 16 may be built into the catheter 60, which may, for example, be located near the point of deployment of the mesh 7. The element switches 15 have to carry significant power during the ablation phase.
[0038] The mode selection 17 selects between a mapping mode (position shown in the drawing) and an ablation mode (second position of switch). In the mapping mode, a current is created by a voltage source 18 and resistor 19 (e.g., forming a constant current source) and routed into a selected element 10 by the element switches 15. For each measurement, the two element switches 15 that are connected to the scanned element 10 are in an enabled state (ON), the rest of the element switches being in a disabled state (OFF). The voltage drop across an element 10 is measured by an analog to digital (A/D) converter 20 and fed to a control computer 23. For greater accuracy, four terminal sensing can be employed. In a preferred embodiment, the detection is AC coupled, therefore the DC voltage drops along the wires are of no consequence, and no four-terminal sensing is needed. For AC coupling, the control computer 23 may include a 0.5 Hz low pass filter, which may be implemented in software. The slight disadvantage of the AC coupled method approach is speed, as the low signal frequency (e.g., about 1 Hz), requires a few seconds per measurement. Other temperature sensors and/or approaches, such as thermistors or thermocouples, can be used in conjunction with the elements 10. Mapping is achieved by turning on all of the elements 10 (e.g., sequentially) and measuring the temperature of each. A map may be formed in the control computer 23 and the lower temperature spots on the mesh correspond to the openings or ports 8 leading to the veins or valves.
[0039] When the mode selection switch 17 is in the ablation mode, a generator 21 (e.g., Radio Frequency (RF)) is connected (e.g., sequentially) to selected elements 10 by the control computer 23 addressing the multiplexer 22 which controls the element switches 15 via the de-multiplex selector 16. The complete operation, including scanning and ablation, can be completed in less than 5 minutes. The configuration illustrated in FIG. 5 implies unipolar ablation; however bipolar ablation can be used as well and is discussed below. Clearly other sources of ablation can be used besides RF. Frequencies from DC to microwaves can be used, as well as delivery of laser power via optical fibers or cryogenics via thin tubes. For laser ablation element switches 15 are optical switches, while for cryogenic ablation the element switches 15 are valves, and in some embodiments may take the form of heated elements such as resistive wires.
[0040] During ablation it is desirable to monitor the temperature of the mode selection switch 17 to the mapping position several times during the ablation procedure. The measured temperatures can be displayed on a display 32 (FIG. 7 ). RF ablation is typically performed at frequencies of 100 KHz-1 MHz and power levels which depend on the size of the elements 10, but can be as high as 100 W. Various RF ablation techniques and equipment are well known in the art.
[0041] FIG. 6 shows an embodiment in which the mapping system is separate from the ablation system. In this system, the mesh 7 has very few connecting wires. As illustrated, each longitudinal wire 25 has a single output wire and each cross wire 26 has a single output wire 13. For a 10×10 mesh 7 with 100 nodes, only twenty-one wires are needed (ten plus ten plus ground wire), instead of two hundred wires. This allows all wires to be brought directly out of the catheter 60. This also allows placement of selector switches 16 and 24 together with the control system. For example, if the element marked as “A” is selected; a current is selected to run through the longitudinal wire 25 which includes element A. The voltage drop is sensed by the two circumferential wires 13 that connect directly to A. Since no current flows in the other elements at the time of measurement, the voltage drop is only caused by element A. It is sensed by A/D converter 20 via double pole selector 24.
[0042] After a map is established, it is displayed on a display screen 32 as shown in FIG. 7 . The surgeon can select which elements 10 will cause tissue ablation in the atrium. The pattern formed is along the line of the standard Maze procedure. The location of the pulmonary veins 5 and the mitral valve 9 is inferred from the temperature date and drawn on the display screen.
[0043] FIGS. 8A and 8B demonstrate the principle of accurate location of the veins and valves even if the grid is relatively coarse. The exact location can be interpolated based on the fact that when only part of the element 10 is exposed to the blood flow. By the way of example, if the temperature of the mesh 7 is 1 degree C. above blood temperature and equals the blood temperature under normal blood flow (this was experimentally verified), the temperatures of a group of elements 10 will be as shown in FIG. 8A when aligned with the opening or port 8 of vein 5. The number near each element 10 is the temperature drop. When moved, some of the elements 10 will only be partially positioned in the flow path under vein 5, as shown by FIG. 8B . The temperatures of those elements 10 will be between 0 and 1 degree above blood temperature. The exact temperature drop between 0 to 1 corresponds with the exact shift. This allows accurate determination of the location and size of each opening or port 8, data used by the control computer 23 to draw the map shown in FIG. 7 . A grid spacing of 10 mm allows about 1 mm accuracy.
[0044] An alternative to a full mesh is a partial mesh, or even a single sensor, that is mechanically scanned across the area to be mapped. FIG. 9 shows a linear sensor array 27 pushed into the atrium 2 via vein 4 by the catheter 60. The linear sensor array 27 has a linear array of elements 10 similar to those used in the full mesh 7. After a linear mapping is performed the linear sensor array 27 is rotated (as shown by broken line 27′) a small amount (10-20 degrees) by stem 11 (similar to electrical wires 6) and a new scan is performed. The same procedures previously described may be used for ablation.
[0045] FIG. 10 shows the use of a single steerable catheter 28 as a mapping and ablation tool. Steerable catheters are controlled remotely by mechanical, magnetic, hydraulic or other means. A steerable catheter 28 can be used to scan the inside of the atrium 3 by bending, as shown in broken line 28′. The location is monitored by external or internal sensors. A position of a tip of the steerable catheter 28 can also be monitored by fluoroscopy. The catheter tip contains a heating and/or ablation element 10. Steerable catheters 28 may advantageously carry a wide range of ablation systems, since only one connection and one point is needed.
[0046] A full mesh trades a higher complexity for better speed and accuracy when compared to linear arrays or single point scanning.
[0047] The previous examples were of unipolar ablation, with the ablation current returning to ground via the patient's body. The disclosed system can also be used for bipolar ablation as shown in FIG. 11 . In unipolar ablation the same voltage is connected to both leads 13 and 13′ of an element 10. In bipolar ablation the voltage is connected to lead 13 while the other end, 13′, is grounded. It is important that the element 10 will be of sufficient resistance to cause most of the ablation current to flow through heart tissue 1. Electrodes 30 make contact with tissue 1 while the wire used in the element 10 is covered by an insulator. The advantage of bipolar ablation is better control of ablation depth. Typical ablation temperatures are 60-80 degrees C. At a higher temperature the tissue 1 becomes less conductive, forcing the ablation current to seek a new path. This promotes full ablation of the tissue 1. The element 10 can also be designed to assist ablation by creating heat when ablation voltage is applied across it.
[0048] One possible advantage of at least some of the presently disclosed embodiments over electrical potential mapping methods is that the presently disclosed embodiments do not require perfect contact between the mesh 7 and the tissue 1. The presently disclosed embodiments may also advantageously be less sensitive to the surface properties of the tissue, such as scar tissue or plaque.
[0049] If the mesh is separated from the tissue by a thin layer of blood, both the temperature sensing and the ablation functions of the presently disclosed embodiments will still function properly.
[0050] The word “element” in this disclosure has to be interpreted in a broad sense as any element capable of sensing blood flow. Clearly the elements do not need to be heaters, as cooling elements will work equally well. If a material is injected into the blood flow, any sensor capable of detecting this material can be used to detect blood flow. By the way of example, if the blood is cooled or warmed slightly before returning to the heart only temperatures sensors are needed. Since temperature differences as low as 0.1 degree C. can be detected reliably, it is fairly simple to heat or cool the blood slightly before it returns to the heart (even by a simple external pad).
[0051] The above description of illustrated embodiments, including what is described in the Abstract, is not intended to be exhaustive or to limit the embodiments to the precise forms disclosed. Although specific embodiments of and examples are described herein for illustrative purposes, various equivalent modifications can be made without departing from the spirit and scope of the disclosure, as will be recognized by those skilled in the relevant art.
[0052] The various embodiments described above can be combined to provide further embodiments. All of the U.S. patents. U.S. patent application publications, U.S. patent applications, foreign patents, foreign patent applications and non-patent publications referred to in this specification and/or listed in the Application Data Sheet are incorporated herein by reference, in their entirety. Aspects of the embodiments can be modified, if necessary, to employ systems, circuits and concepts of the various patents, applications and publications to provide yet further embodiments.
[0053] These and other changes can be made to the embodiments in light of the above-detailed description. In general. in the following claims, the terms used should not be construed to limit the claims to the specific embodiments disclosed in the specification and the claims, but should be construed to include all possible embodiments along with the full scope of equivalents to which such claims are entitled. Accordingly, the claims are not limited by the disclosure.
Claims
Certificate of Correction present
The claims shown below may not include correction changes. Use the corrected PDF for authoritative text.
What is claimed is:
1. A medical system comprising:
a catheter including a meshed structure, the meshed structure including a plurality of vertices, each vertex of at least a first vertex of the plurality of vertices being where four segments of the meshed structure are attached, the meshed structure comprising a proximal end and a distal end, the meshed structure configured to be delivered to a bodily organ with the distal end ahead of the proximal end, and the first vertex located on the meshed structure between the proximal end and the distal end of the meshed structure; and
a control computer operatively coupled via a wire connection configuration to the meshed structure and configured, for at least the first vertex of the plurality of vertices, to cause delivery of tissue ablative energy to tissue at least proximate a first segment of the four segments of the meshed structure attached at the first vertex independently of causing delivery of tissue ablative energy to tissue at least proximate a second segment of the four segments of the meshed structure attached at the first vertex.
2. The medical system of claim 1, wherein each segment of the four segments of the meshed structure attached at the first vertex comprises an external metallic portion extending along at least part of the segment, the external metallic portion configured to deliver tissue ablative energy, and the external metallic portion configured to be exposed to blood flow.
3. The medical system of claim 2, wherein the external metallic portion is wound around an interior portion of the segment of the four segments of the meshed structure attached at the first vertex.
4. The medical system of claim 1, wherein the meshed structure is configured to expand from a compressed configuration to an expanded configuration.
5. The medical system of claim 1, wherein the meshed structure comprises a sensor operatively coupled to the control computer, the sensor located adjacent each of the first segment and the second segment of the four segments of the meshed structure attached at the first vertex of the plurality of vertices.
6. The medical system of claim 5, wherein the sensor is located on a third segment of the four segments of the meshed structure attached at the first vertex of the plurality of vertices.
7. The medical system of claim 5, wherein the sensor is operatively coupled to the control computer to sense temperature.
8. The medical system of claim 5, wherein the sensor is operatively coupled to the control computer to sense tissue contact.
9. The medical system of claim 1, wherein the plurality of vertices comprises a second vertex, and wherein the catheter comprises a coiled sensor mounted on a particular segment of the meshed structure that is attached with at least another segment of the meshed structure at the second vertex.
10. The medical system of claim 9, wherein the coiled sensor is configured to determine a position of the meshed structure in the bodily organ.
11. The medical system of claim 9, wherein the control computer is configured to map the bodily organ based at least on information provided by the coiled sensor.
12. A medical system comprising:
a catheter including a meshed structure including a plurality of vertices and a plurality of segments between the plurality of vertices; and
a control computer operatively coupled via a wire connection configuration to the meshed structure and configured to independently control a first portion of the meshed structure to sense a tissue characteristic and to cause a second portion of the meshed structure to cause tissue ablation, the second portion of the meshed structure distinct from the first portion of the meshed structure, and the second portion and the first portion coupled to a same particular vertex of the plurality of vertices, a group of segments of the plurality of segments attached at the same vertex.
13. The medical system of claim 12, wherein the second portion of the meshed structure includes at least an external metallic portion of a first segment of the group of segments, the external metallic portion configured to be exposed to blood.
14. The medical system of claim 13, wherein the external metallic portion is wound around an interior portion of the first segment of the group of segments.
15. The medical system of claim 13, wherein the first portion of the meshed structure is adjacent each of the first segment of the group of segments and a second segment of the group of segments.
16. The medical system of claim 15, wherein the first portion of the meshed structure comprises a third segment of the group of segments, wherein a sensor is located on the third segment of the group of segments, the sensor configured to sense the tissue characteristic.
17. The medical system of claim 12, wherein the second portion of the meshed structure includes at least an external metallic portion of each of at least a first segment of the group of segments and a second segment of the group of segments, the external metallic portions configured to be exposed to blood.
18. The medical system of claim 17, wherein the first portion of the meshed structure is adjacent each of the first segment of the group of segments and the second segment of the group of segments.
19. The medical system of claim 18, wherein the first portion of the meshed structure comprises a third segment of the group of segments, wherein a sensor is located on the third segment of the group of segments, the sensor configured to sense the tissue characteristic.
20. The medical system of claim 12, wherein the meshed structure is configured to expand from a compressed configuration to an expanded configuration.
21. The medical system of claim 12, wherein the segments of the group of segments are physically connected to one another at the same particular vertex.
22. The medical system of claim 12, wherein the catheter comprises a coiled sensor mounted on one of the plurality of segments attached at a second vertex of the plurality of vertices.
23. The medical system of claim 22, wherein the coiled sensor is configured to determine a position of the meshed structure in a bodily organ.
24. The medical system of claim 22, wherein the control computer is configured to map a bodily organ based at least on information provided by the coiled sensor.
25. A medical system comprising:
a catheter including a meshed structure; and
a control computer operatively coupled to a plurality of control leads that are coupled to the meshed structure to cause tissue ablation or a sensing operation,
wherein the meshed structure is configured to expand from a compressed configuration to an expanded configuration, the plurality of control leads hanging within the meshed structure at least in the expanded configuration, and each control lead of the plurality of control leads coupled to a different portion of the meshed structure than every other control lead of the plurality of control leads, and
wherein the meshed structure comprises a plurality of segments and a plurality of vertices, each vertex of the plurality of vertices being where more than two segments of the plurality of segments are attached, and each control lead of at least some of the plurality of control leads is coupled to a location on the meshed structure between two vertices of the plurality of vertices.
26. The medical system of claim 25, wherein each control lead of at least some of the plurality of control leads is coupled to a sensor located on the meshed structure.
27. The medical system of claim 25, wherein each control lead of at least some of the plurality of control leads is coupled to an ablation electrode located on the meshed structure.
28. The medical system of claim 25, wherein the plurality of segments meshed structure comprises a plurality of interconnected metallic segments, each control lead of at least some of the plurality of control leads is coupled to a metallic segment of the plurality of interconnected metallic segments.
29. The medical system of claim 25, wherein each control lead of at least some of the plurality of control leads is coupled to a segment of the plurality of segments.
30. The medical system of claim 25, wherein the catheter comprises a coiled sensor mounted on one of the segments attached at a first vertex of the plurality of vertices.
31. The medical system of claim 30, wherein the coiled sensor is configured to determine a position of the meshed structure in a bodily organ.
32. The medical system of claim 30, wherein the control computer is configured to map a bodily organ based at least on information provided by the coiled sensor.
33. The medical system of claim 25, comprising a shaft, each of the plurality of control leads exiting the shaft to within the meshed structure at least when the meshed structure is in the expanded configuration.
34. A medical system comprising:
a catheter including a meshed structure comprising a plurality of segments, the meshed structure including a plurality of vertices, each vertex of the plurality of vertices being where more than two segments of the plurality of segments are attached; and
a control computer operatively coupled to a plurality of control leads that are coupled to the meshed structure among the vertices of the meshed structure to cause tissue ablation or a sensing operation, the control leads distinct from the plurality of segments.
35. A medical system comprising:
a catheter including a meshed structure, the meshed structure including a plurality of vertices, the meshed structure comprising a proximal end and a distal end, the meshed structure configured to be delivered to a bodily organ with the distal end ahead of the proximal end, and a first vertex of the plurality of vertices located on the meshed structure between the proximal end and the distal end of the meshed structure, and a first segment of the meshed structure leading into the first vertex of the plurality of vertices stiffer than a second segment of the meshed structure leading into the first vertex of the plurality of vertices; and
a control computer operatively coupled via a wire connection configuration to the meshed structure and configured to cause delivery of tissue ablative energy to tissue at least proximate at least a portion of the meshed structure.
Patent Citations (751)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| US4114202(A) | 1978-09-01 | Roy et al. | Applicant |
| US4164046(A) | 1979-08-01 | Cooley | Applicant |
| US4225148(A) | 1980-09-01 | Andersson | Applicant |
| US4240441(A) | 1980-12-01 | Khalil | Applicant |
| US4263680(A) | 1981-04-01 | Reul et al. | Applicant |
| US4273128(A) | 1981-06-01 | Lary | Applicant |
| US4411266(A) | 1983-10-01 | Cosman | Applicant |
| US4490859(A) | 1985-01-01 | Black et al. | Applicant |
| US4543090(A) | 1985-09-01 | McCoy | Applicant |
| US4576182(A) | 1986-03-01 | Normann | Applicant |
| US4699147(A) | 1987-10-01 | Chilson et al. | Applicant |
| US4770187(A) | 1988-09-01 | Lash et al. | Applicant |
| US4787369(A) | 1988-11-01 | Allred, III et al. | Applicant |
| US4794912(A) | 1989-01-01 | Lia | Applicant |
| US4850957(A) | 1989-07-01 | Summers | Applicant |
| US4887613(A) | 1989-12-01 | Farr et al. | Applicant |
| US4890602(A) | 1990-01-01 | Hake | Applicant |
| US4890612(A) | 1990-01-01 | Kensey | Applicant |
| US4893613(A) | 1990-01-01 | Hake | Applicant |
| US4895166(A) | 1990-01-01 | Farr et al. | Applicant |
| US4905667(A) | 1990-03-01 | Foerster et al. | Applicant |
| US4921499(A) | 1990-05-01 | Hoffman et al. | Applicant |
| US4940064(A) | 1990-07-01 | Desai | Applicant |
| US4942788(A) | 1990-07-01 | Farr et al. | Applicant |
| US4979514(A) | 1990-12-01 | Sekii et al. | Applicant |
| US4998933(A) | 1991-03-01 | Eggers et al. | Applicant |
| US5026384(A) | 1991-06-01 | Farr et al. | Applicant |
| US5047047(A) | 1991-09-01 | Yoon | Applicant |
| US5122137(A) | 1992-06-01 | Lennox | Applicant |
| US5127902(A) | 1992-07-01 | Fischell | Applicant |
| US5153151(A) | 1992-10-01 | Aitken | Applicant |
| US5156151(A) | 1992-10-01 | Imran | Applicant |
| US5174299(A) | 1992-12-01 | Nelson | Applicant |
| US5176693(A) | 1993-01-01 | Pannek, Jr. | Applicant |
| US5178620(A) | 1993-01-01 | Eggers et al. | Applicant |
| US5192291(A) | 1993-03-01 | Pannek, Jr. | Applicant |
| US5195505(A) | 1993-03-01 | Josefsen | Applicant |
| US5201316(A) | 1993-04-01 | Pomeranz et al. | Applicant |
| US5228442(A) | 1993-07-01 | Imran | Applicant |
| US5242386(A) | 1993-09-01 | Holzer | Applicant |
| US5245987(A) | 1993-09-01 | Redmond et al. | Applicant |
| US5255679(A) | 1993-10-01 | Imran | Applicant |
| US5279299(A) | 1994-01-01 | Imran | Applicant |
| US5293869(A) | 1994-03-01 | Edwards et al. | Applicant |
| US5297549(A) | 1994-03-01 | Beatty et al. | Applicant |
| US5309910(A) | 1994-05-01 | Edwards et al. | Applicant |
| US5311866(A) | 1994-05-01 | Kagan | Applicant |
| US5312435(A) | 1994-05-01 | Nash et al. | Applicant |
| US5317952(A) | 1994-06-01 | Immega | Applicant |
| US5324284(A) | 1994-06-01 | Imran | Applicant |
| US5327889(A) | 1994-07-01 | Imran | Applicant |
| US5341807(A) | 1994-08-01 | Nardella | Applicant |
| US5345936(A) | 1994-09-01 | Pomeranz et al. | Applicant |
| US5351551(A) | 1994-10-01 | Drubetsky | Applicant |
| US5351679(A) | 1994-10-01 | Mayzels et al. | Applicant |
| US5366443(A) | 1994-11-01 | Eggers et al. | Applicant |
| US5370679(A) | 1994-12-01 | Atlee, III | Applicant |
| US5379773(A) | 1995-01-01 | Hornsby | Applicant |
| US5397321(A) | 1995-03-01 | Houser et al. | Applicant |
| US5419767(A) | 1995-05-01 | Eggers et al. | Applicant |
| US5450860(A) | 1995-09-01 | O'Connor | Applicant |
| US5456254(A) | 1995-10-01 | Pietroski et al. | Applicant |
| US5462545(A) | 1995-10-01 | Wang | Applicant |
| US5465717(A) | 1995-11-01 | Imran et al. | Applicant |
| US5478353(A) | 1995-12-01 | Yoon | Applicant |
| US5485849(A) | 1996-01-01 | Panescu et al. | Applicant |
| US5496267(A) | 1996-03-01 | Drasler et al. | Applicant |
| US5496330(A) | 1996-03-01 | Bates | Applicant |
| US5499981(A) | 1996-03-01 | Kordis | Applicant |
| US5531760(A) | 1996-07-01 | Alwafaie | Applicant |
| US5545193(A) | 1996-08-01 | Fleischman et al. | Applicant |
| US5549108(A) | 1996-08-01 | Edwards et al. | Applicant |
| US5549661(A) | 1996-08-01 | Kordis et al. | Applicant |
| US5555883(A) | 1996-09-01 | Avitall | Applicant |
| US5557967(A) | 1996-09-01 | Renger | Applicant |
| US5575810(A) | 1996-11-01 | Swanson et al. | Applicant |
| US5577509(A) | 1996-11-01 | Panescu | Applicant |
| US5582609(A) | 1996-12-01 | Swanson | Examiner |
| US5593424(A) | 1997-01-01 | Northrup, III | Applicant |
| US5595183(A) | 1997-01-01 | Swanson | Applicant |
| US5598848(A) | 1997-02-01 | Swanson et al. | Applicant |
| US5599345(A) | 1997-02-01 | Edwards et al. | Applicant |
| US5620481(A) | 1997-04-01 | Desai et al. | Applicant |
| US5630813(A) | 1997-05-01 | Kieturakis | Applicant |
| US5636634(A) | 1997-06-01 | Kordis | Applicant |
| US5637090(A) | 1997-06-01 | McGee et al. | Applicant |
| US5662587(A) | 1997-09-01 | Grundfest et al. | Applicant |
| US5681308(A) | 1997-10-01 | Edwards et al. | Applicant |
| US5681336(A) | 1997-10-01 | Clement et al. | Applicant |
| US5687723(A) | 1997-11-01 | Avitall | Applicant |
| US5687737(A) | 1997-11-01 | Branham et al. | Applicant |
| US5697285(A) | 1997-12-01 | Nappi et al. | Applicant |
| US5704914(A) | 1998-01-01 | Stocking | Applicant |
| US5713896(A) | 1998-02-01 | Nardella | Applicant |
| US5713942(A) | 1998-02-01 | Stern et al. | Applicant |
| US5716397(A) | 1998-02-01 | Myers | Applicant |
| US5718241(A) | 1998-02-01 | Ben-Haim | Applicant |
| US5720726(A) | 1998-02-01 | Marcadis et al. | Applicant |
| US5728114(A) | 1998-03-01 | Evans et al. | Applicant |
| US5730127(A) | 1998-03-01 | Avitall | Applicant |
| US5738096(A) | 1998-04-01 | Ben-Haim | Applicant |
| US5762066(A) | 1998-06-01 | Law et al. | Applicant |
| US5769846(A) | 1998-06-01 | Edwards et al. | Applicant |
| US5782239(A) | 1998-07-01 | Webster, Jr. | Applicant |
| US5782879(A) | 1998-07-01 | Rosborough et al. | Applicant |
| US5797903(A) | 1998-08-01 | Swanson | Examiner |
| US5800495(A) | 1998-09-01 | Machek et al. | Applicant |
| US5823189(A) | 1998-10-01 | Kordis | Applicant |
| US5824066(A) | 1998-10-01 | Gross | Applicant |
| US5831159(A) | 1998-11-01 | Renger | Applicant |
| US5836947(A) | 1998-11-01 | Fleischman et al. | Applicant |
| US5836990(A) | 1998-11-01 | Li | Applicant |
| US5853422(A) | 1998-12-01 | Huebsch et al. | Applicant |
| US5868743(A) | 1999-02-01 | Saul | Applicant |
| US5868755(A) | 1999-02-01 | Kanner et al. | Applicant |
| US5876343(A) | 1999-03-01 | Teo | Applicant |
| US5879295(A) | 1999-03-01 | Li et al. | Applicant |
| US5881727(A) | 1999-03-01 | Edwards | Applicant |
| US5885278(A) | 1999-03-01 | Fleischman | Applicant |
| US5891136(A) | 1999-04-01 | McGee et al. | Applicant |
| US5893847(A) | 1999-04-01 | Kordis | Applicant |
| US5904711(A) | 1999-05-01 | Flom et al. | Applicant |
| US5916163(A) | 1999-06-01 | Panescu et al. | Applicant |
| US5919207(A) | 1999-07-01 | Taheri | Applicant |
| US5921924(A) | 1999-07-01 | Avitall | Applicant |
| US5935075(A) | 1999-08-01 | Casscells et al. | Applicant |
| US5935079(A) | 1999-08-01 | Swanson et al. | Applicant |
| US5941251(A) | 1999-08-01 | Panescu et al. | Applicant |
| US5944715(A) | 1999-08-01 | Goble et al. | Applicant |
| US5961440(A) | 1999-10-01 | Schweich, Jr. et al. | Applicant |
| US5968040(A) | 1999-10-01 | Swanson et al. | Applicant |
| US5984950(A) | 1999-11-01 | Cragg et al. | Applicant |
| US6001069(A) | 1999-12-01 | Tachibana et al. | Applicant |
| US6001093(A) | 1999-12-01 | Swanson et al. | Applicant |
| US6014581(A) | 2000-01-01 | Whayne et al. | Applicant |
| US6023638(A) | 2000-02-01 | Swanson | Applicant |
| US6030382(A) | 2000-02-01 | Fleischman et al. | Applicant |
| US6036689(A) | 2000-03-01 | Tu et al. | Applicant |
| US6063082(A) | 2000-05-01 | DeVore et al. | Applicant |
| US6071282(A) | 2000-06-01 | Fleischman | Applicant |
| US6078830(A) | 2000-06-01 | Levin | Examiner |
| US6104944(A) | 2000-08-01 | Martinelli | Applicant |
| US6106460(A) | 2000-08-01 | Panescu | Applicant |
| US6106522(A) | 2000-08-01 | Fleischman et al. | Applicant |
| US6119030(A) | 2000-09-01 | Morency | Applicant |
| US6123702(A) | 2000-09-01 | Swanson et al. | Applicant |
| US6138043(A) | 2000-10-01 | Avitall | Applicant |
| US6142993(A) | 2000-11-01 | Whayne et al. | Applicant |
| US6156046(A) | 2000-12-01 | Passafaro et al. | Applicant |
| US6210432(B1) | 2001-04-01 | Solem et al. | Applicant |
| US6216043(B1) | 2001-04-01 | Swanson et al. | Applicant |
| US6217573(B1) | 2001-04-01 | Webster | Applicant |
| US6240307(B1) | 2001-05-01 | Beatty | Applicant |
| US6241747(B1) | 2001-06-01 | Ruff | Applicant |
| US6245064(B1) | 2001-06-01 | Lesh et al. | Applicant |
| US6248124(B1) | 2001-06-01 | Pedros et al. | Applicant |
| US6254598(B1) | 2001-07-01 | Edwards | Applicant |
| US6258258(B1) | 2001-07-01 | Sartori et al. | Applicant |
| US6266550(B1) | 2001-07-01 | Selmon et al. | Applicant |
| US6304769(B1) | 2001-10-01 | Arenson et al. | Applicant |
| US6306135(B1) | 2001-10-01 | Ellman et al. | Applicant |
| US6308091(B1) | 2001-10-01 | Avitall | Applicant |
| US6319249(B1) | 2001-11-01 | Tollner | Applicant |
| US6322559(B1) | 2001-11-01 | Daulton et al. | Applicant |
| US6330478(B1) | 2001-12-01 | Lee et al. | Applicant |
| US6346105(B1) | 2002-02-01 | Tu et al. | Applicant |
| US6350263(B1) | 2002-02-01 | Wetzig et al. | Applicant |
| US6358258(B1) | 2002-03-01 | Arcia et al. | Applicant |
| US6383151(B1) | 2002-05-01 | Diederich et al. | Applicant |
| US6389311(B1) | 2002-05-01 | Whayne et al. | Applicant |
| US6391024(B1) | 2002-05-01 | Sun et al. | Applicant |
| US6391048(B1) | 2002-05-01 | Ginn et al. | Applicant |
| US6391054(B2) | 2002-05-01 | Carpentier et al. | Applicant |
| US6402781(B1) | 2002-06-01 | Langberg et al. | Applicant |
| US6428537(B1) | 2002-08-01 | Swanson | Applicant |
| US6436052(B1) | 2002-08-01 | Nikolic et al. | Applicant |
| US6471693(B1) | 2002-10-01 | Carroll | Applicant |
| US6475223(B1) | 2002-11-01 | Werp et al. | Applicant |
| US6485409(B1) | 2002-11-01 | Voloshin et al. | Applicant |
| US6485482(B1) | 2002-11-01 | Belef | Applicant |
| US6485489(B2) | 2002-11-01 | Teirstein et al. | Applicant |
| US6506210(B1) | 2003-01-01 | Kanner | Applicant |
| US6514249(B1) | 2003-02-01 | Maguire et al. | Applicant |
| US6517534(B1) | 2003-02-01 | McGovern | Applicant |
| US6529756(B1) | 2003-03-01 | Phan et al. | Applicant |
| US6537198(B1) | 2003-03-01 | Vidlund et al. | Applicant |
| US6537314(B2) | 2003-03-01 | Langberg et al. | Applicant |
| US6540670(B1) | 2003-04-01 | Hirata et al. | Applicant |
| US6551310(B1) | 2003-04-01 | Ganz et al. | Applicant |
| US6551312(B2) | 2003-04-01 | Zhang et al. | Applicant |
| US6569160(B1) | 2003-05-01 | Goldin et al. | Applicant |
| US6569198(B1) | 2003-05-01 | Wilson et al. | Applicant |
| US6575971(B2) | 2003-06-01 | Hauck et al. | Applicant |
| US6589208(B2) | 2003-07-01 | Ewers et al. | Applicant |
| US6616684(B1) | 2003-09-01 | Vidlund et al. | Applicant |
| US6626930(B1) | 2003-09-01 | Allen et al. | Applicant |
| US6632238(B2) | 2003-10-01 | Ginn et al. | Applicant |
| US6635056(B2) | 2003-10-01 | Kadhiresan et al. | Applicant |
| US6640119(B1) | 2003-10-01 | Budd et al. | Applicant |
| US6652515(B1) | 2003-11-01 | Maguire et al. | Applicant |
| US6652517(B1) | 2003-11-01 | Hall et al. | Applicant |
| US6662034(B2) | 2003-12-01 | Segner et al. | Applicant |
| US6666862(B2) | 2003-12-01 | Jain et al. | Applicant |
| USD484979(S) | 2004-01-01 | Fontaine | Applicant |
| US6704590(B2) | 2004-03-01 | Haldeman | Applicant |
| US6723038(B1) | 2004-04-01 | Schroeder et al. | Applicant |
| US6725085(B2) | 2004-04-01 | Schwartzman et al. | Applicant |
| US6726716(B2) | 2004-04-01 | Marquez | Applicant |
| US6733499(B2) | 2004-05-01 | Scheib | Applicant |
| US6735465(B2) | 2004-05-01 | Panescu | Applicant |
| US6760616(B2) | 2004-07-01 | Hoey et al. | Applicant |
| US6780197(B2) | 2004-08-01 | Roe et al. | Applicant |
| US6788969(B2) | 2004-09-01 | Dupree et al. | Applicant |
| US6795721(B2) | 2004-09-01 | Coleman et al. | Applicant |
| US6797001(B2) | 2004-09-01 | Mathis et al. | Applicant |
| US6800090(B2) | 2004-10-01 | Alferness et al. | Applicant |
| US6824562(B2) | 2004-11-01 | Mathis et al. | Applicant |
| US6837886(B2) | 2005-01-01 | Collins et al. | Applicant |
| US6852076(B2) | 2005-02-01 | Nikolic et al. | Applicant |
| US6855143(B2) | 2005-02-01 | Davison et al. | Applicant |
| US6890353(B2) | 2005-05-01 | Cohn et al. | Applicant |
| US6892091(B1) | 2005-05-01 | Ben-Haim et al. | Applicant |
| US6899674(B2) | 2005-05-01 | Viebach et al. | Applicant |
| US6907297(B2) | 2005-06-01 | Wellman et al. | Applicant |
| US6908478(B2) | 2005-06-01 | Alferness et al. | Applicant |
| US6913576(B2) | 2005-07-01 | Bowman | Applicant |
| US6918903(B2) | 2005-07-01 | Bass | Applicant |
| US6926669(B1) | 2005-08-01 | Stewart et al. | Applicant |
| US6936047(B2) | 2005-08-01 | Nasab et al. | Applicant |
| US6942657(B2) | 2005-09-01 | Sinofsky et al. | Applicant |
| US6949122(B2) | 2005-09-01 | Adams et al. | Applicant |
| US6955640(B2) | 2005-10-01 | Sanders et al. | Applicant |
| US6960206(B2) | 2005-11-01 | Keane | Applicant |
| US6960229(B2) | 2005-11-01 | Mathis et al. | Applicant |
| US6966908(B2) | 2005-11-01 | Maguire et al. | Applicant |
| US6986775(B2) | 2006-01-01 | Morales et al. | Applicant |
| US6989010(B2) | 2006-01-01 | Francischelli et al. | Applicant |
| US6989028(B2) | 2006-01-01 | Lashinski et al. | Applicant |
| US6994093(B2) | 2006-02-01 | Murphy et al. | Applicant |
| US6997925(B2) | 2006-02-01 | Maguire et al. | Applicant |
| US6997951(B2) | 2006-02-01 | Solem et al. | Applicant |
| US7001383(B2) | 2006-02-01 | Keidar | Applicant |
| US7003342(B2) | 2006-02-01 | Plaza | Applicant |
| US7025776(B1) | 2006-04-01 | Houser et al. | Applicant |
| US7044135(B2) | 2006-05-01 | Lesh | Applicant |
| US7048734(B1) | 2006-05-01 | Fleischman et al. | Applicant |
| US7050848(B2) | 2006-05-01 | Hoey et al. | Applicant |
| US7052487(B2) | 2006-05-01 | Cohn et al. | Applicant |
| US7068867(B2) | 2006-06-01 | Adoram et al. | Applicant |
| US7141019(B2) | 2006-11-01 | Pearlman | Applicant |
| US7144363(B2) | 2006-12-01 | Pai et al. | Applicant |
| US7166127(B2) | 2007-01-01 | Spence et al. | Applicant |
| US7174201(B2) | 2007-02-01 | Govari et al. | Applicant |
| US7177677(B2) | 2007-02-01 | Kaula et al. | Applicant |
| US7186210(B2) | 2007-03-01 | Feld et al. | Applicant |
| US7187964(B2) | 2007-03-01 | Khoury | Applicant |
| US7189202(B2) | 2007-03-01 | Lau et al. | Applicant |
| US7194294(B2) | 2007-03-01 | Panescu et al. | Applicant |
| US7198635(B2) | 2007-04-01 | Danek et al. | Applicant |
| US7252664(B2) | 2007-08-01 | Nasab et al. | Applicant |
| US7255695(B2) | 2007-08-01 | Falwell et al. | Applicant |
| US7276044(B2) | 2007-10-01 | Ferry et al. | Applicant |
| US7279007(B2) | 2007-10-01 | Nikolic et al. | Applicant |
| US7282030(B2) | 2007-10-01 | Frei et al. | Applicant |
| US7300435(B2) | 2007-11-01 | Wham et al. | Applicant |
| US7303526(B2) | 2007-12-01 | Sharkey et al. | Applicant |
| US7335196(B2) | 2008-02-01 | Swanson et al. | Applicant |
| US7340307(B2) | 2008-03-01 | Maguire et al. | Applicant |
| US7481808(B2) | 2009-01-01 | Koyfman et al. | Applicant |
| US7507252(B2) | 2009-03-01 | Lashinski et al. | Applicant |
| US7530980(B2) | 2009-05-01 | Hooven | Applicant |
| US7575566(B2) | 2009-08-01 | Scheib | Applicant |
| US7593760(B2) | 2009-09-01 | Rodriguez et al. | Applicant |
| US7610078(B2) | 2009-10-01 | Willis | Applicant |
| US7633502(B2) | 2009-12-01 | Willis et al. | Applicant |
| US7660452(B2) | 2010-02-01 | Zwirn et al. | Applicant |
| US7736388(B2) | 2010-06-01 | Goldfarb et al. | Applicant |
| US7738967(B2) | 2010-06-01 | Salo | Applicant |
| US7740584(B2) | 2010-06-01 | Donaldson | Applicant |
| US7877128(B2) | 2011-01-01 | Schwartz | Applicant |
| US8012149(B2) | 2011-09-01 | Jackson | Applicant |
| US8103338(B2) | 2012-01-01 | Harlev et al. | Applicant |
| USD654588(S) | 2012-02-01 | Taube et al. | Applicant |
| US8118853(B2) | 2012-02-01 | Grewe | Applicant |
| US8150499(B2) | 2012-04-01 | Gelbart et al. | Applicant |
| USD660967(S) | 2012-05-01 | Braido et al. | Applicant |
| US8200308(B2) | 2012-06-01 | Zhang et al. | Applicant |
| US8216216(B2) | 2012-07-01 | Warnking et al. | Applicant |
| US8221411(B2) | 2012-07-01 | Francischelli et al. | Applicant |
| US8224432(B2) | 2012-07-01 | Macadam et al. | Applicant |
| US8326419(B2) | 2012-12-01 | Rosenberg et al. | Applicant |
| US8352019(B2) | 2013-01-01 | Starks | Applicant |
| US8398631(B2) | 2013-03-01 | Ganz | Applicant |
| US8401645(B2) | 2013-03-01 | Rosenberg et al. | Applicant |
| US8414508(B2) | 2013-04-01 | Thapliyal et al. | Applicant |
| US8442613(B2) | 2013-05-01 | Kim et al. | Applicant |
| US8442625(B2) | 2013-05-01 | Markowitz et al. | Applicant |
| US8457371(B2) | 2013-06-01 | Markowitz et al. | Applicant |
| US8463368(B2) | 2013-06-01 | Harlev et al. | Applicant |
| US8532734(B2) | 2013-09-01 | Markowitz et al. | Applicant |
| US8562559(B2) | 2013-10-01 | Bishop | Applicant |
| US8571647(B2) | 2013-10-01 | Harlev et al. | Applicant |
| US8615287(B2) | 2013-12-01 | Harlev et al. | Applicant |
| US8657814(B2) | 2014-02-01 | Werneth et al. | Applicant |
| US8663120(B2) | 2014-03-01 | Markowitz et al. | Applicant |
| US8706260(B2) | 2014-04-01 | Stewart et al. | Applicant |
| US8725240(B2) | 2014-05-01 | Harlev et al. | Applicant |
| US8831701(B2) | 2014-09-01 | Markowitz et al. | Applicant |
| US8834461(B2) | 2014-09-01 | Werneth et al. | Applicant |
| US8849384(B2) | 2014-09-01 | Greenspan | Applicant |
| US8864745(B2) | 2014-10-01 | Ciavarella | Applicant |
| USD717954(S) | 2014-11-01 | Hjelle et al. | Applicant |
| US8897516(B2) | 2014-11-01 | Turgeman | Applicant |
| US8920411(B2) | 2014-12-01 | Gelbart et al. | Applicant |
| US8926605(B2) | 2015-01-01 | Mccarthy et al. | Applicant |
| US8932284(B2) | 2015-01-01 | Mccarthy et al. | Applicant |
| US8961506(B2) | 2015-02-01 | Mccarthy et al. | Applicant |
| US9033893(B2) | 2015-05-01 | Spector | Applicant |
| US9044245(B2) | 2015-06-01 | Condie et al. | Applicant |
| US9095350(B2) | 2015-08-01 | Condie et al. | Applicant |
| US9101333(B2) | 2015-08-01 | Schwartz | Applicant |
| US9107599(B2) | 2015-08-01 | Harlev et al. | Applicant |
| US9119633(B2) | 2015-09-01 | Gelbart et al. | Applicant |
| US9119634(B2) | 2015-09-01 | Gelbart et al. | Applicant |
| US9179860(B2) | 2015-11-01 | Markowitz et al. | Applicant |
| US9179972(B2) | 2015-11-01 | Olson | Applicant |
| US9198713(B2) | 2015-12-01 | Wallace et al. | Applicant |
| US9204935(B2) | 2015-12-01 | Hauck et al. | Applicant |
| US9265434(B2) | 2016-02-01 | Merschon et al. | Applicant |
| US9277872(B2) | 2016-03-01 | Harlev et al. | Applicant |
| US9277960(B2) | 2016-03-01 | Weinkam et al. | Applicant |
| US9282910(B2) | 2016-03-01 | Narayan et al. | Applicant |
| US9289606(B2) | 2016-03-01 | Paul | Applicant |
| US9332920(B2) | 2016-05-01 | Thakur et al. | Applicant |
| US9398862(B2) | 2016-07-01 | Harlev et al. | Applicant |
| US9408544(B2) | 2016-08-01 | Laughner et al. | Applicant |
| US9433465(B2) | 2016-09-01 | Gliner et al. | Applicant |
| US9439578(B2) | 2016-09-01 | Thakur et al. | Applicant |
| US9456759(B2) | 2016-10-01 | Lian et al. | Applicant |
| US9474491(B2) | 2016-10-01 | Li et al. | Applicant |
| US9486272(B2) | 2016-11-01 | Bonyak et al. | Applicant |
| US9504518(B2) | 2016-11-01 | Condie et al. | Applicant |
| US9532725(B2) | 2017-01-01 | Laughner et al. | Applicant |
| US9532828(B2) | 2017-01-01 | Condie et al. | Applicant |
| US9554718(B2) | 2017-01-01 | Bar-Tal et al. | Applicant |
| US9554847(B2) | 2017-01-01 | Govari et al. | Applicant |
| US9572620(B2) | 2017-02-01 | Ryu et al. | Applicant |
| US9579064(B2) | 2017-02-01 | Kovtun et al. | Applicant |
| US9603651(B2) | 2017-03-01 | Ghosh | Applicant |
| US9603661(B2) | 2017-03-01 | Gelbart et al. | Applicant |
| US9610045(B2) | 2017-04-01 | Du et al. | Applicant |
| US9622806(B2) | 2017-04-01 | Mihalik | Applicant |
| US9629567(B2) | 2017-04-01 | Porath et al. | Applicant |
| US9636032(B2) | 2017-05-01 | Thakur et al. | Applicant |
| US9655535(B2) | 2017-05-01 | Narayan et al. | Applicant |
| US9662033(B2) | 2017-05-01 | Severino | Applicant |
| US9693699(B2) | 2017-07-01 | Spector et al. | Applicant |
| US9730603(B2) | 2017-08-01 | Laughner et al. | Applicant |
| US9737267(B2) | 2017-08-01 | Strom et al. | Applicant |
| US9743854(B2) | 2017-08-01 | Stewart et al. | Applicant |
| US9763587(B2) | 2017-09-01 | Altmann | Applicant |
| US9763625(B2) | 2017-09-01 | Laughner et al. | Applicant |
| US9782094(B2) | 2017-10-01 | Du et al. | Applicant |
| US9795314(B2) | 2017-10-01 | Laughner et al. | Applicant |
| US9814523(B2) | 2017-11-01 | Condie et al. | Applicant |
| US9848833(B2) | 2017-12-01 | Govari et al. | Applicant |
| US9861431(B2) | 2018-01-01 | Goshayeshgar | Applicant |
| US9861802(B2) | 2018-01-01 | Mickelsen | Applicant |
| US9875578(B2) | 2018-01-01 | Zar et al. | Applicant |
| US9895079(B2) | 2018-02-01 | Massarwa et al. | Applicant |
| US9913589(B2) | 2018-03-01 | Scharf et al. | Applicant |
| US9918649(B2) | 2018-03-01 | Thakur et al. | Applicant |
| US9918788(B2) | 2018-03-01 | Paul et al. | Applicant |
| US9940747(B2) | 2018-04-01 | Katz et al. | Applicant |
| US9949657(B2) | 2018-04-01 | Ravuna et al. | Applicant |
| US9955889(B2) | 2018-05-01 | Urman et al. | Applicant |
| US9980653(B2) | 2018-05-01 | Lichtenstein et al. | Applicant |
| US9987083(B2) | 2018-06-01 | Gelbart et al. | Applicant |
| US9987084(B2) | 2018-06-01 | Gelbart et al. | Applicant |
| US10004413(B2) | 2018-06-01 | Bokan et al. | Applicant |
| US10010368(B2) | 2018-07-01 | Laske et al. | Applicant |
| US10016145(B2) | 2018-07-01 | Thakur et al. | Applicant |
| US10028783(B2) | 2018-07-01 | Gelbart et al. | Applicant |
| US10064678(B2) | 2018-09-01 | Corvi et al. | Applicant |
| US10085659(B2) | 2018-10-01 | Laughner et al. | Applicant |
| US11141219(B1) | 2021-10-01 | Schwarz | Applicant |
| US2001/0003158(A1) | 2001-06-01 | Kensey et al. | Applicant |
| US2001/0005787(A1) | 2001-06-01 | Oz et al. | Applicant |
| US2001/0018611(A1) | 2001-08-01 | Solem et al. | Applicant |
| US2001/0020126(A1) | 2001-09-01 | Swanson et al. | Applicant |
| US2001/0021867(A1) | 2001-09-01 | Kordis et al. | Applicant |
| US2002/0002329(A1) | 2002-01-01 | Avitall | Applicant |
| US2002/0016628(A1) | 2002-02-01 | Langberg et al. | Applicant |
| US2002/0087156(A1) | 2002-07-01 | Maguire et al. | Applicant |
| US2002/0087157(A1) | 2002-07-01 | Sliwa, Jr. et al. | Applicant |
| US2002/0087173(A1) | 2002-07-01 | Alferness et al. | Applicant |
| US2002/0099415(A1) | 2002-07-01 | Panescu et al. | Applicant |
| US2002/0107478(A1) | 2002-08-01 | Wendlandt | Applicant |
| US2002/0107511(A1) | 2002-08-01 | Collins | Examiner |
| US2002/0107530(A1) | 2002-08-01 | Saucer et al. | Applicant |
| US2002/0115941(A1) | 2002-08-01 | Whayne et al. | Applicant |
| US2002/0115944(A1) | 2002-08-01 | Mendes et al. | Applicant |
| US2002/0165535(A1) | 2002-11-01 | Lesh et al. | Applicant |
| US2002/0169445(A1) | 2002-11-01 | Jain et al. | Applicant |
| US2002/0169504(A1) | 2002-11-01 | Alferness et al. | Applicant |
| US2002/0173784(A1) | 2002-11-01 | Sliwa, Jr. et al. | Applicant |
| US2002/0177782(A1) | 2002-11-01 | Penner | Applicant |
| US2002/0183836(A1) | 2002-12-01 | Liddicoat et al. | Applicant |
| US2002/0183841(A1) | 2002-12-01 | Cohn et al. | Applicant |
| US2002/0188170(A1) | 2002-12-01 | Santamore et al. | Applicant |
| US2003/0028118(A1) | 2003-02-01 | Dupree et al. | Applicant |
| US2003/0028183(A1) | 2003-02-01 | Sanchez et al. | Applicant |
| US2003/0050637(A1) | 2003-03-01 | Maguire et al. | Applicant |
| US2003/0050685(A1) | 2003-03-01 | Nikolic et al. | Applicant |
| US2003/0055420(A1) | 2003-03-01 | Kadhiresan et al. | Applicant |
| US2003/0060820(A1) | 2003-03-01 | Maguire et al. | Applicant |
| US2003/0069570(A1) | 2003-04-01 | Witzel et al. | Applicant |
| US2003/0069636(A1) | 2003-04-01 | Solem et al. | Applicant |
| US2003/0078465(A1) | 2003-04-01 | Pai et al. | Applicant |
| US2003/0078494(A1) | 2003-04-01 | Panescu et al. | Applicant |
| US2003/0078509(A1) | 2003-04-01 | Panescu | Applicant |
| US2003/0078671(A1) | 2003-04-01 | Lesniak et al. | Applicant |
| US2003/0105384(A1) | 2003-06-01 | Sharkey et al. | Applicant |
| US2003/0105520(A1) | 2003-06-01 | Alferness et al. | Applicant |
| US2003/0109770(A1) | 2003-06-01 | Sharkey et al. | Applicant |
| US2003/0125726(A1) | 2003-07-01 | Maguire et al. | Applicant |
| US2003/0176810(A1) | 2003-09-01 | Maahs et al. | Applicant |
| US2003/0181819(A1) | 2003-09-01 | Desai | Applicant |
| US2003/0229395(A1) | 2003-12-01 | Cox | Applicant |
| US2004/0002626(A1) | 2004-01-01 | Feld et al. | Applicant |
| US2004/0006337(A1) | 2004-01-01 | Nasab et al. | Applicant |
| US2004/0054279(A1) | 2004-03-01 | Hanley | Applicant |
| US2004/0082915(A1) | 2004-04-01 | Kadan | Applicant |
| US2004/0133220(A1) | 2004-07-01 | Lashinski et al. | Applicant |
| US2004/0133273(A1) | 2004-07-01 | Cox | Applicant |
| US2004/0138744(A1) | 2004-07-01 | Lashinski et al. | Applicant |
| US2004/0153146(A1) | 2004-08-01 | Lashinski et al. | Applicant |
| US2004/0158321(A1) | 2004-08-01 | Reuter et al. | Applicant |
| US2004/0176797(A1) | 2004-09-01 | Opolski | Applicant |
| US2004/0181139(A1) | 2004-09-01 | Falwell | Examiner |
| US2004/0186566(A1) | 2004-09-01 | Hindrichs et al. | Applicant |
| US2004/0193103(A1) | 2004-09-01 | Kumar | Applicant |
| US2004/0215232(A1) | 2004-10-01 | Belhe et al. | Applicant |
| US2004/0243170(A1) | 2004-12-01 | Suresh et al. | Applicant |
| US2004/0249408(A1) | 2004-12-01 | Murphy et al. | Applicant |
| US2004/0249453(A1) | 2004-12-01 | Cartledge et al. | Applicant |
| US2004/0267358(A1) | 2004-12-01 | Reitan | Applicant |
| US2005/0004668(A1) | 2005-01-01 | Aklog et al. | Applicant |
| US2005/0010206(A1) | 2005-01-01 | Nasab et al. | Applicant |
| US2005/0015109(A1) | 2005-01-01 | Lichtenstein | Applicant |
| US2005/0054938(A1) | 2005-03-01 | Wehman et al. | Applicant |
| US2005/0055089(A1) | 2005-03-01 | Macoviak et al. | Applicant |
| US2005/0060030(A1) | 2005-03-01 | Lashinski et al. | Applicant |
| US2005/0064665(A1) | 2005-03-01 | Han | Applicant |
| US2005/0065420(A1) | 2005-03-01 | Collins et al. | Applicant |
| US2005/0065504(A1) | 2005-03-01 | Melsky et al. | Applicant |
| US2005/0080402(A1) | 2005-04-01 | Santamore et al. | Applicant |
| US2005/0096047(A1) | 2005-05-01 | Haberman et al. | Applicant |
| US2005/0096647(A1) | 2005-05-01 | Steinke | Examiner |
| US2005/0107723(A1) | 2005-05-01 | Wehman et al. | Applicant |
| US2005/0107871(A1) | 2005-05-01 | Realyvasquez et al. | Applicant |
| US2005/0125030(A1) | 2005-06-01 | Forsberg et al. | Applicant |
| US2005/0148892(A1) | 2005-07-01 | Desai | Applicant |
| US2005/0149014(A1) | 2005-07-01 | Hauck et al. | Applicant |
| US2005/0149159(A1) | 2005-07-01 | Andreas et al. | Applicant |
| US2005/0154252(A1) | 2005-07-01 | Sharkey et al. | Applicant |
| US2005/0165388(A1) | 2005-07-01 | Bhola | Applicant |
| US2005/0182365(A1) | 2005-08-01 | Hennemann et al. | Applicant |
| US2005/0187491(A1) | 2005-08-01 | Burbank | Applicant |
| US2005/0187620(A1) | 2005-08-01 | Pai et al. | Applicant |
| US2005/0197593(A1) | 2005-09-01 | Burbank et al. | Applicant |
| US2005/0197692(A1) | 2005-09-01 | Pai et al. | Applicant |
| US2005/0197693(A1) | 2005-09-01 | Pai et al. | Applicant |
| US2005/0197694(A1) | 2005-09-01 | Pai et al. | Applicant |
| US2005/0203558(A1) | 2005-09-01 | Maschke | Applicant |
| US2005/0209636(A1) | 2005-09-01 | Widomski et al. | Applicant |
| US2005/0216054(A1) | 2005-09-01 | Widomski et al. | Applicant |
| US2005/0240249(A1) | 2005-10-01 | Tu et al. | Applicant |
| US2005/0245892(A1) | 2005-11-01 | Elkins | Applicant |
| US2005/0251116(A1) | 2005-11-01 | Steinke et al. | Applicant |
| US2005/0251132(A1) | 2005-11-01 | Oral et al. | Applicant |
| US2005/0256521(A1) | 2005-11-01 | Kozel | Applicant |
| US2005/0261580(A1) | 2005-11-01 | Willis et al. | Applicant |
| US2005/0267458(A1) | 2005-12-01 | Paul et al. | Applicant |
| US2005/0267463(A1) | 2005-12-01 | Vanney | Applicant |
| US2005/0267574(A1) | 2005-12-01 | Cohn et al. | Applicant |
| US2006/0009755(A1) | 2006-01-01 | Sra | Applicant |
| US2006/0009756(A1) | 2006-01-01 | Francischelli et al. | Applicant |
| US2006/0014998(A1) | 2006-01-01 | Sharkey et al. | Applicant |
| US2006/0015002(A1) | 2006-01-01 | Moaddeb et al. | Applicant |
| US2006/0015003(A1) | 2006-01-01 | Moaddes et al. | Applicant |
| US2006/0015038(A1) | 2006-01-01 | Weymarn-Scharli | Applicant |
| US2006/0015096(A1) | 2006-01-01 | Hauck et al. | Applicant |
| US2006/0025800(A1) | 2006-02-01 | Suresh | Applicant |
| US2006/0030881(A1) | 2006-02-01 | Sharkey et al. | Applicant |
| US2006/0084966(A1) | 2006-04-01 | Maguire et al. | Applicant |
| US2006/0085049(A1) | 2006-04-01 | Cory et al. | Applicant |
| US2006/0089637(A1) | 2006-04-01 | Werneth et al. | Applicant |
| US2006/0100475(A1) | 2006-05-01 | White et al. | Applicant |
| US2006/0100618(A1) | 2006-05-01 | Chan et al. | Applicant |
| US2006/0106298(A1) | 2006-05-01 | Ahmed et al. | Applicant |
| US2006/0135968(A1) | 2006-06-01 | Schaller | Applicant |
| US2006/0135970(A1) | 2006-06-01 | Schaller | Applicant |
| US2006/0173251(A1) | 2006-08-01 | Govari et al. | Applicant |
| US2006/0184242(A1) | 2006-08-01 | Lichtenstein | Applicant |
| US2006/0199995(A1) | 2006-09-01 | Vijay | Applicant |
| US2006/0229491(A1) | 2006-10-01 | Sharkey et al. | Applicant |
| US2006/0235286(A1) | 2006-10-01 | Stone et al. | Applicant |
| US2006/0235314(A1) | 2006-10-01 | Migliuolo et al. | Applicant |
| US2006/0264980(A1) | 2006-11-01 | Khairkhahan et al. | Applicant |
| US2006/0281965(A1) | 2006-12-01 | Khairkhahan et al. | Applicant |
| US2006/0293698(A1) | 2006-12-01 | Douk | Applicant |
| US2006/0293725(A1) | 2006-12-01 | Rubinsky et al. | Applicant |
| US2007/0016068(A1) | 2007-01-01 | Grunwald et al. | Applicant |
| US2007/0027533(A1) | 2007-02-01 | Douk | Applicant |
| US2007/0038208(A1) | 2007-02-01 | Kefer | Applicant |
| US2007/0083168(A1) | 2007-04-01 | Whiting | Applicant |
| US2007/0083193(A1) | 2007-04-01 | Werneth et al. | Applicant |
| US2007/0083195(A1) | 2007-04-01 | Werneth et al. | Applicant |
| US2007/0088362(A1) | 2007-04-01 | Bonutti et al. | Applicant |
| US2007/0115390(A1) | 2007-05-01 | Makara et al. | Applicant |
| US2007/0118215(A1) | 2007-05-01 | Moaddeb | Applicant |
| US2007/0129717(A1) | 2007-06-01 | Brown et al. | Applicant |
| US2007/0161846(A1) | 2007-07-01 | Nikolic et al. | Applicant |
| US2007/0198058(A1) | 2007-08-01 | Gelbart et al. | Applicant |
| US2007/0213578(A1) | 2007-09-01 | Khairkhahan et al. | Applicant |
| US2007/0213815(A1) | 2007-09-01 | Khairkhahan et al. | Applicant |
| US2007/0232858(A1) | 2007-10-01 | Macnamara et al. | Applicant |
| US2007/0249999(A1) | 2007-10-01 | Sklar et al. | Applicant |
| US2007/0270688(A1) | 2007-11-01 | Gelbart et al. | Applicant |
| US2007/0299343(A1) | 2007-12-01 | Waters | Applicant |
| US2008/0004534(A1) | 2008-01-01 | Gelbart et al. | Applicant |
| US2008/0004643(A1) | 2008-01-01 | To et al. | Applicant |
| US2008/0004697(A1) | 2008-01-01 | Lichtenstein et al. | Applicant |
| US2008/0045778(A1) | 2008-02-01 | Lichtenstein et al. | Applicant |
| US2008/0071298(A1) | 2008-03-01 | Khairkhahan et al. | Applicant |
| US2008/0172048(A1) | 2008-07-01 | Martin et al. | Applicant |
| US2008/0262337(A1) | 2008-10-01 | Falwell et al. | Applicant |
| US2008/0281322(A1) | 2008-11-01 | Sherman et al. | Applicant |
| US2008/0312713(A1) | 2008-12-01 | Wilfley et al. | Applicant |
| US2009/0018617(A1) | 2009-01-01 | Skelton et al. | Applicant |
| US2009/0024138(A1) | 2009-01-01 | Saleh | Applicant |
| US2009/0069704(A1) | 2009-03-01 | MacAdam et al. | Applicant |
| US2009/0131930(A1) | 2009-05-01 | Gelbart et al. | Applicant |
| US2009/0157058(A1) | 2009-06-01 | Ferren et al. | Applicant |
| US2009/0171274(A1) | 2009-07-01 | Harlev et al. | Applicant |
| US2009/0182325(A1) | 2009-07-01 | Werneth et al. | Applicant |
| US2009/0182405(A1) | 2009-07-01 | Arnault De La Menardiere | Applicant |
| US2009/0192441(A1) | 2009-07-01 | Gelbart et al. | Applicant |
| US2009/0253976(A1) | 2009-10-01 | Harlev et al. | Applicant |
| US2009/0270737(A1) | 2009-10-01 | Thornton | Applicant |
| US2009/0287271(A1) | 2009-11-01 | Blum et al. | Applicant |
| US2009/0287304(A1) | 2009-11-01 | Dahlgren et al. | Applicant |
| US2010/0016762(A1) | 2010-01-01 | Thapliyal et al. | Applicant |
| US2010/0023004(A1) | 2010-01-01 | Francischelli et al. | Applicant |
| US2010/0113928(A1) | 2010-05-01 | Thapliyal et al. | Applicant |
| US2010/0113985(A1) | 2010-05-01 | Thapliyal et al. | Applicant |
| US2010/0121147(A1) | 2010-05-01 | Oskin et al. | Applicant |
| US2010/0204560(A1) | 2010-08-01 | Salahieh | Applicant |
| US2010/0211052(A1) | 2010-08-01 | Brown et al. | Applicant |
| US2010/0249771(A1) | 2010-09-01 | Pearson et al. | Applicant |
| US2010/0268059(A1) | 2010-10-01 | Ryu et al. | Applicant |
| US2010/0268260(A1) | 2010-10-01 | Riina et al. | Applicant |
| US2010/0286551(A1) | 2010-11-01 | Harlev et al. | Applicant |
| US2011/0034912(A1) | 2011-02-01 | De Graff et al. | Applicant |
| US2011/0125172(A1) | 2011-05-01 | Gelbart et al. | Applicant |
| US2011/0172658(A1) | 2011-07-01 | Gelbart et al. | Applicant |
| US2011/0213231(A1) | 2011-09-01 | Hall et al. | Applicant |
| US2011/0282491(A1) | 2011-11-01 | Prisco et al. | Applicant |
| US2012/0071870(A1) | 2012-03-01 | Salahieh | Applicant |
| US2012/0078076(A1) | 2012-03-01 | Stewart et al. | Applicant |
| US2012/0136346(A1) | 2012-05-01 | Condie et al. | Applicant |
| US2012/0136348(A1) | 2012-05-01 | Condie et al. | Applicant |
| US2012/0158016(A1) | 2012-06-01 | Gelbart et al. | Applicant |
| US2012/0165829(A1) | 2012-06-01 | Chen et al. | Applicant |
| US2012/0172859(A1) | 2012-07-01 | Condie et al. | Applicant |
| US2012/0172867(A1) | 2012-07-01 | Ryu et al. | Applicant |
| US2012/0271135(A1) | 2012-10-01 | Burke et al. | Applicant |
| US2012/0277567(A1) | 2012-11-01 | Harlev et al. | Applicant |
| US2013/0066220(A1) | 2013-03-01 | Weinkam et al. | Applicant |
| US2013/0165916(A1) | 2013-06-01 | Mathur et al. | Applicant |
| US2013/0172883(A1) | 2013-07-01 | Lopes et al. | Applicant |
| US2013/0178850(A1) | 2013-07-01 | Lopes et al. | Applicant |
| US2013/0178851(A1) | 2013-07-01 | Lopes et al. | Applicant |
| US2013/0184705(A1) | 2013-07-01 | Gelbart et al. | Applicant |
| US2013/0184706(A1) | 2013-07-01 | Gelbart et al. | Applicant |
| US2013/0190587(A1) | 2013-07-01 | Lopes et al. | Applicant |
| US2013/0190741(A1) | 2013-07-01 | Moll et al. | Applicant |
| US2013/0197513(A1) | 2013-08-01 | Lopes et al. | Applicant |
| US2013/0241929(A1) | 2013-09-01 | Massarwa et al. | Applicant |
| US2013/0274562(A1) | 2013-10-01 | Ghaffari et al. | Applicant |
| US2013/0296679(A1) | 2013-11-01 | Condie et al. | Applicant |
| US2013/0296850(A1) | 2013-11-01 | Olson | Applicant |
| US2013/0304065(A1) | 2013-11-01 | Lopes et al. | Applicant |
| US2013/0310828(A1) | 2013-11-01 | Reinders et al. | Applicant |
| US2013/0345538(A1) | 2013-12-01 | Harlev et al. | Applicant |
| US2014/0114307(A1) | 2014-04-01 | Moisa et al. | Applicant |
| US2014/0121659(A1) | 2014-05-01 | Paul et al. | Applicant |
| US2014/0213894(A1) | 2014-07-01 | Gelbart et al. | Applicant |
| US2014/0296850(A1) | 2014-10-01 | Condie et al. | Applicant |
| US2014/0303610(A1) | 2014-10-01 | Mccarthy et al. | Applicant |
| US2014/0303614(A1) | 2014-10-01 | Mccarthy et al. | Applicant |
| US2014/0350552(A1) | 2014-11-01 | Highsmith | Applicant |
| US2014/0364848(A1) | 2014-12-01 | Heimbecher et al. | Applicant |
| US2015/0045660(A1) | 2015-02-01 | Gelbart et al. | Applicant |
| US2015/0105701(A1) | 2015-04-01 | Mayer et al. | Applicant |
| US2015/0126993(A1) | 2015-05-01 | Gelbart et al. | Applicant |
| US2015/0157400(A1) | 2015-06-01 | Gelbart et al. | Applicant |
| US2015/0182740(A1) | 2015-07-01 | Mickelsen | Applicant |
| US2015/0245798(A1) | 2015-09-01 | Gelbart et al. | Applicant |
| US2015/0250539(A1) | 2015-09-01 | Gelbart et al. | Applicant |
| US2015/0351837(A1) | 2015-12-01 | Gelbart et al. | Applicant |
| US2015/0366508(A1) | 2015-12-01 | Chou et al. | Applicant |
| US2016/0008061(A1) | 2016-01-01 | Fung et al. | Applicant |
| US2016/0058505(A1) | 2016-03-01 | Condie et al. | Applicant |
| US2016/0106498(A1) | 2016-04-01 | Highsmith | Applicant |
| US2016/0287137(A1) | 2016-10-01 | Condie et al. | Applicant |
| US2016/0346030(A1) | 2016-12-01 | Thapliyal et al. | Applicant |
| US2016/0361111(A1) | 2016-12-01 | Seidel | Applicant |
| US2016/0367315(A1) | 2016-12-01 | Moisa et al. | Applicant |
| US2017/0020604(A1) | 2017-01-01 | Lopes et al. | Applicant |
| US2017/0035486(A1) | 2017-02-01 | Lopes et al. | Applicant |
| US2017/0035499(A1) | 2017-02-01 | Stewart et al. | Applicant |
| US2017/0065339(A1) | 2017-03-01 | Mickelsen | Applicant |
| US2017/0065340(A1) | 2017-03-01 | Long | Applicant |
| US2017/0079712(A1) | 2017-03-01 | Levin et al. | Applicant |
| US2017/0092013(A1) | 2017-03-01 | Perlman et al. | Applicant |
| US2017/0103570(A1) | 2017-04-01 | Zar et al. | Applicant |
| US2017/0105627(A1) | 2017-04-01 | Katz et al. | Applicant |
| US2017/0119453(A1) | 2017-05-01 | Ryu et al. | Applicant |
| US2017/0143414(A1) | 2017-05-01 | Sliwa et al. | Applicant |
| US2017/0156792(A1) | 2017-06-01 | Ziv-Ari et al. | Applicant |
| US2017/0202470(A1) | 2017-07-01 | Urman et al. | Applicant |
| US2017/0202516(A1) | 2017-07-01 | Bar-Tal et al. | Applicant |
| US2017/0202521(A1) | 2017-07-01 | Urman et al. | Applicant |
| US2017/0312012(A1) | 2017-11-01 | Harlev et al. | Applicant |
| US2017/0333124(A1) | 2017-11-01 | Gelbart et al. | Applicant |
| US2018/0036074(A1) | 2018-02-01 | Gelbart et al. | Applicant |
| US2018/0036075(A1) | 2018-02-01 | Gelbart et al. | Applicant |
| US2018/0036076(A1) | 2018-02-01 | Gelbart et al. | Applicant |
| US2018/0036077(A1) | 2018-02-01 | Gelbart et al. | Applicant |
| US2018/0042671(A1) | 2018-02-01 | Gelbart et al. | Applicant |
| US2018/0042674(A1) | 2018-02-01 | Mickelsen | Applicant |
| US2018/0042675(A1) | 2018-02-01 | Long | Applicant |
| US2018/0055565(A1) | 2018-03-01 | Gelbart et al. | Applicant |
| US2018/0056074(A1) | 2018-03-01 | Clark et al. | Applicant |
| US2018/0064488(A1) | 2018-03-01 | Long et al. | Applicant |
| US2018/0068439(A1) | 2018-03-01 | Hareland | Applicant |
| US2018/0093088(A1) | 2018-04-01 | Mickelsen | Applicant |
| US2018/0110561(A1) | 2018-04-01 | Levin et al. | Applicant |
| US2018/0125575(A1) | 2018-05-01 | Schwartz et al. | Applicant |
| US2018/0158238(A1) | 2018-06-01 | Cohen et al. | Applicant |
| US2018/0160978(A1) | 2018-06-01 | Cohen et al. | Applicant |
| US2018/0161097(A1) | 2018-06-01 | Zoabi et al. | Applicant |
| US2018/0177467(A1) | 2018-06-01 | Katz et al. | Applicant |
| US2018/0177552(A1) | 2018-06-01 | Zoabi et al. | Applicant |
| US2018/0182157(A1) | 2018-06-01 | Zar et al. | Applicant |
| US2018/0182159(A1) | 2018-06-01 | Cohen et al. | Applicant |
| US2018/0190009(A1) | 2018-07-01 | Cohen et al. | Applicant |
| US2018/0199976(A1) | 2018-07-01 | Fischer | Applicant |
| US2018/0199990(A1) | 2018-07-01 | Monir et al. | Applicant |
| US2018/0200497(A1) | 2018-07-01 | Mickelsen | Applicant |
| US2018/0206920(A1) | 2018-07-01 | Pappone et al. | Applicant |
| US2018/0214202(A1) | 2018-08-01 | Howard et al. | Applicant |
| US2018/0242868(A1) | 2018-08-01 | Cohen et al. | Applicant |
| US2018/0256055(A1) | 2018-09-01 | Zigelman et al. | Applicant |
| US2018/0296114(A1) | 2018-10-01 | Welsh et al. | Applicant |
| US2018/0325597(A1) | 2018-11-01 | Schwartz et al. | Applicant |
| US2019/0046265(A1) | 2019-02-01 | Moisa et al. | Applicant |
| US2019/0223950(A1) | 2019-07-01 | Gelbart | Applicant |
| US2019/0307506(A1) | 2019-10-01 | Gelbart | Applicant |
| US2019/0328452(A1) | 2019-10-01 | Gelbart | Applicant |
| US2019/0343570(A1) | 2019-11-01 | Lopes | Applicant |
| US2019/0365449(A1) | 2019-12-01 | Lopes | Applicant |
| US2019/0380760(A1) | 2019-12-01 | Lopes | Applicant |
| US2020/0046425(A1) | 2020-02-01 | Lopes | Applicant |
| US2020/0046426(A1) | 2020-02-01 | Gelbart | Applicant |
| US2020/0054394(A1) | 2020-02-01 | Gelbart | Applicant |
| US2020/0375659(A1) | 2020-12-01 | Gelbart | Applicant |
| US2021/0000537(A1) | 2021-01-01 | Gelbart | Applicant |
| US2021/0059750(A1) | 2021-03-01 | Gelbart | Applicant |
| US2021/0169544(A1) | 2021-06-01 | Lopes | Applicant |
| US2024/0115316(A1) | 2024-04-01 | Lopes et al. | Applicant |
| CN101797181(A) | 2010-08-01 | Applicant | |
| DE102010026210(A1) | 2012-01-01 | Applicant | |
| DE102011085720(A1) | 2013-05-01 | Applicant | |
| EP723467(A1) | 1996-07-01 | Applicant | |
| EP1169976(A1) | 2002-01-01 | Applicant | |
| EP1240868(A1) | 2002-09-01 | Applicant | |
| EP1182980(B1) | 2006-06-01 | Applicant | |
| EP1280467(B1) | 2008-11-01 | Applicant | |
| EP1451595(B1) | 2009-07-01 | Applicant | |
| EP1909679(B1) | 2013-11-01 | Applicant | |
| EP2307098(B1) | 2015-03-01 | Applicant | |
| EP2848191(A1) | 2015-03-01 | Applicant | |
| EP2873365(A1) | 2015-05-01 | Applicant | |
| EP2984986(A2) | 2016-02-01 | Applicant | |
| EP2645953(B1) | 2016-08-01 | Applicant | |
| EP2661236(B1) | 2016-08-01 | Applicant | |
| EP2749213(B1) | 2016-09-01 | Applicant | |
| EP2604211(B1) | 2016-10-01 | Applicant | |
| EP3130285(A1) | 2017-02-01 | Applicant | |
| EP3141185(A1) | 2017-03-01 | Applicant | |
| EP2689722(B1) | 2017-06-01 | Applicant | |
| EP2613723(B1) | 2017-10-01 | Applicant | |
| EP3225161(A1) | 2017-10-01 | Applicant | |
| EP2892454(B1) | 2018-01-01 | Applicant | |
| EP3318211(A2) | 2018-05-01 | Applicant | |
| EP3321890(A1) | 2018-05-01 | Applicant | |
| EP3139997(B1) | 2018-09-01 | Applicant | |
| EP3375365(A2) | 2018-09-01 | Applicant | |
| WO9510320(A1) | 1995-04-01 | Applicant | |
| WO95/20349(A1) | 1995-08-01 | Applicant | |
| WO97/17892(A1) | 1997-05-01 | Applicant | |
| WO108575(A2) | 2001-02-01 | Applicant | |
| WO2/087437(A1) | 2002-11-01 | Applicant | |
| WO3015611(A2) | 2003-02-01 | Applicant | |
| WO3077800(A1) | 2003-09-01 | Applicant | |
| WO2004012629(A1) | 2004-02-01 | Applicant | |
| WO2004047679(A1) | 2004-06-01 | Applicant | |
| WO2004084746(A2) | 2004-10-01 | Applicant | |
| WO2004100803(A1) | 2004-11-01 | Applicant | |
| WO2005070330(A1) | 2005-08-01 | Applicant | |
| WO2005102181(A1) | 2005-11-01 | Applicant | |
| WO2006017809(A2) | 2006-02-01 | Applicant | |
| WO2006105121(A2) | 2006-10-01 | Applicant | |
| WO2006135747(A2) | 2006-12-01 | Applicant | |
| WO2006135749(A2) | 2006-12-01 | Applicant | |
| WO2007021647(A2) | 2007-02-01 | Applicant | |
| WO2007115390(A1) | 2007-10-01 | Applicant | |
| WO2008002606(A2) | 2008-01-01 | Applicant | |
| WO2009011721(A1) | 2009-01-01 | Applicant | |
| WO2009065042(A2) | 2009-05-01 | Applicant | |
| WO2012050877(A1) | 2012-04-01 | Applicant | |
| WO2012/100184(A2) | 2012-07-01 | Applicant | |
| WO2012/100185(A2) | 2012-07-01 | Applicant | |
| WO2013064576(A1) | 2013-05-01 | Applicant | |
| WO2013/173917(A1) | 2013-11-01 | Applicant | |
| WO2016181317(A2) | 2016-11-01 | Applicant | |
| WO2016181318(A1) | 2016-11-01 | Applicant | |
| WO2016183468(A1) | 2016-11-01 | Applicant | |
| WO2017009165(A1) | 2017-01-01 | Applicant | |
| WO2017024123(A1) | 2017-02-01 | Applicant | |
| WO2017087740(A1) | 2017-05-01 | Applicant | |
| WO2017120169(A1) | 2017-07-01 | Applicant | |
| WO2017192480(A2) | 2017-11-01 | Applicant | |
| WO2017192495(A1) | 2017-11-01 | Applicant | |
| WO2017192510(A2) | 2017-11-01 | Applicant | |
| WO2017192542(A2) | 2017-11-01 | Applicant | |
| WO2018023132(A1) | 2018-02-01 | Applicant | |
| WO2018165425(A1) | 2018-09-01 | Applicant |
Non-Patent Literature (347)
- Lopes et al., “Intra-Cardiac Procedure Device”, Amendment filed in U.S. Appl. No. 29/509,636, filed Jul. 22, 2016, 5 pgs.Applicant
- Lopes et al., “Intra-Cardiac Procedure Device”, Amendment filed in U.S. Appl. No. 29/509,636 on Nov. 17, 2016, 3 pgs.Applicant
- Lopes et al., “High-Density Electrode-Based Medical Device System”, Preliminary Amendment filed in U.S. Appl. No. 15/287,988 on Nov. 23, 2016, 9 pgs.Applicant
- Lopes et al., “Intra-Cardiac Procedure Device”, Amendment filed in U.S. Appl. No. 29/509,621 on Jul. 22, 2016, 5 pgs.Applicant
- Lopes et al., “Intra-Cardiac Procedure Device”, Amendment filed in U.S. Appl. No. 29/509,621 on Nov. 17, 2016, 3 pgs.Applicant
- Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Amendment filed in U.S. Appl. No. 13/782,889 on May 17, 2016, 51 pgs.Applicant
- Lopes et al., “High-Density Electrode-Based Medical Device System” Amendment filed in U.S. Appl. No. 13/793,213 on May 26, 2016, 39 pgs.Applicant
- Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Amendment filed in U.S. Appl. No. 13/782,867 on May 17, 2016, 39 pgs.Applicant
- Gelbart et al., “Intra-Cardiac Mapping and Ablation Method”, Amendment filed in U.S. Appl. No. 11/475,950 on Feb. 12, 2013, 4 pgs.Applicant
- Moisa et al., “Catheter System”, Preliminary Amendment filed in copending U.S. Appl. No. 15/254,130 on Sep. 19, 2016, 22 pgs.Applicant
- Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Preliminary Amendment filed in U.S. Appl. No. 14/804,924 on Jul. 30, 2015, 5 pgs.Applicant
- Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Preliminary Amendment filed in U.S. Appl. No. 14/804,810 on Jul. 30, 2015, 10 pgs.Applicant
- Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Preliminary Amendment filed in U.S. Appl. No. 14/713,190 on May 15, 2015, 3 pgs.Applicant
- Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Preliminary Amendment filed in U.S. Appl. No. 14/713,190 on Jun. 16, 2015, 7 pgs.Applicant
- Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Preliminary Amendment filed in U.S. Appl. No. 14/713,114 on Jun. 16, 2015, 8 pgs.Applicant
- Office Action issued in U.S. Appl. No. 14/521,692 mailed Jan. 10, 2017.Applicant
- Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Amendment filed in U.S. Appl. No. 14/229,305 on Sep. 27, 2016, 15 pgs.Applicant
- Notice of Allowance issued in U.S. Appl. No. 14/229,305 mailed Nov. 8, 2016.Applicant
- Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Amendment filed in U.S. Appl. No. 14/229,250 on Sep. 27, 2016, 13 pgs.Applicant
- Notice of Allowance issued in U.S. Appl. No. 14/229,250 mailed Dec. 7, 2016.Applicant
- Moisa et al., “Catheter System”, Amendment filed in U.S. Appl. No. 14/136,946 on Apr. 18, 2016, 19 pgs.Applicant
- Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Amendment filed in U.S. Appl. No. 13/942,354 on Jan. 4, 2017, 23 pgs.Applicant
- Lopes et al., “High-Density Electrode-Based Medical Device System”, Preliminary Amendment filed in U.S. Appl. No. 13/793,076 on May 26, 2016, 15 pgs.Applicant
- Lopes et al., “High-Density Electrode-Based Medical Device System”, Amendment filed in U.S. Appl. No. 13/793,076 on May 9, 2016, 15 pgs.Applicant
- Gelbart et al., “Apparatus and Method for Intracardiac Mapping and Ablation”, Preliminary Amendment filed in U.S. Appl. No. 13/785,931 on Mar. 5, 2013, 2 pgs.Applicant
- Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Amendment filed in U.S. Appl. No. 13/785,910 on Feb. 9, 2016, 11 pgs.Applicant
- Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Amendment filed in U.S. Appl. No. 13/785,910 on Jan. 5, 2016, 15 pgs.Applicant
- Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Amendment filed in U.S. Appl. No. 13/785,910 on Aug. 8, 2016, 18 pgs.Applicant
- Office Action issued in U.S. Appl. No. 13/785,910 mailed Nov. 2, 2016.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 16/369,528 on Apr. 24, 2019.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 16/381,317 on Apr. 24, 2019.Applicant
- Office Action issued in copending U.S. Appl. No. 15/254,130 mailed May 28, 2019.Applicant
- Notice of Intention to Grant issued in European Application No. 14871405.8 mailed Jan. 22, 2019.Applicant
- Notice of Intention to Grant issued in European Application No. 15188407.9 mailed Mar. 20, 2019.Applicant
- Preliminary Amendment filed in U.S. Appl. No. 15/697,744 on Sep. 21, 2017.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 16/381,344 on Apr. 24, 2019.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 16/407,379 on Jun. 12, 2019.Applicant
- Notice of Intention to Grant issued in EP Appln. No. 13793216.6 mailed Jul. 15, 2019.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 16/521,712 on Jul. 25, 2019.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 16/521,732 on Jul. 25, 2019.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 16/521,745 on Jul. 25, 2019.Applicant
- Amendment filed in copending U.S. Appl. No. 15/254,130 on Aug. 13, 2019.Applicant
- Second Preliminary Amendment filed in copending U.S. Appl. No. 16/521,712 on Aug. 15, 2019.Applicant
- Second Preliminary Amendment filed in copending U.S. Appl. No. 16/521,732 on Aug. 15, 2019.Applicant
- Second Preliminary Amendment filed in copending U.S. Appl. No. 16/521,745 on Aug. 15, 2019.Applicant
- Amendment filed in copending U.S. Appl. No. 16/995,159 on Jan. 24, 2023.Applicant
- Amendment filed in copending U.S. Appl. No. 16/995,222 on Jan. 24, 2023.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 16/521,745 on Feb. 1, 2023.Applicant
- Response filed in copending U.S. Appl. No. 17/072,262 on Feb. 13, 2023.Applicant
- Non-Final Office Action issued in copending U.S. Appl. No. 16/995,222 on Feb. 22, 2023.Applicant
- Non-Final Office Action issued in copending U.S. Appl. No. 17/072,262 on Feb. 23, 2023.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 16/995,159 on Feb. 23, 2023.Applicant
- Non-Final Office Action issued in copending U.S. Appl. No. 16/655,775 on Mar. 6, 2023.Applicant
- Office Action issued in copending U.S. Appl. No. 15/299,640 mailed Nov. 12, 2021.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 15/287,988 mailed Nov. 15, 2021.Applicant
- Office Action issued in copending U.S. Appl. No. 16/662,537 mailed Oct. 29, 2021.Applicant
- Amendment filed in copending U.S. Appl. No. 16/521,712 on Nov. 1, 2021.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 15/299,640 mailed Jun. 1, 2022.Applicant
- Amendment and Statement on the Substance of the Interview filed in copending U.S. Appl. No. 17/584,705 on Jun. 6, 2022.Applicant
- Non-Final Office Action issued in copending U.S. Appl. No. 16/521,732 mailed Jun. 10, 2022.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 17/584,705 mailed Jun. 22, 2022.Applicant
- Non-Final Office Action issued in copending U.S. Appl. No. 16/521,745 mailed Jun. 24, 2022.Applicant
- Response filed in U.S. Appl. No. 16/995,222 on Mar. 14, 2023.Applicant
- Communication under Rule 71(3) EPC issued in European Application No. 13172848.7 mailed Mar. 24, 2023.Applicant
- Response filed in U.S. Appl. No. 17/072,262 on May 2, 2023.Applicant
- Amendment filed in copending U.S. Appl. No. 16/655,775 on May 26, 2023.Applicant
- Final Office Action issued in U.S. Appl. No. 17/072,262 mailed Jun. 26, 2023.Applicant
- Notice of Allowance issued in U.S. Appl. No. 16/995,222, mailed Jul. 6, 2023.Applicant
- Final Office Action issued in copending U.S. Appl. No. 16/655,775 mailed Jul. 11, 2023.Applicant
- Notice of Allowance issued in U.S. Appl. No. 17/072,262, mailed Sep. 7, 2023.Applicant
- Amendment After Final Action filed in U.S. Appl. No. 16/655,775 on Sep. 5, 2023.Applicant
- Notice of Allowance issued in U.S. Appl. No. 16/655,775 mailed Oct. 18, 2023.Applicant
- Communication Under Rule 71(3) EPC issued in European Appln. No. 19215957.2 mailed Sep. 21, 2023.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 18/543,175 on Dec. 20, 2023.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 17/716,303 mailed Apr. 8, 2024.Applicant
- Office Action issued in copending U.S. Appl. No. 17/182,732 mailed May 1, 2024.Applicant
- Extended European Search Report issued in European Appln. No. 24153949.3 mailed Apr. 25, 2024.Applicant
- Communication Under Rule 71(3) EPC issued in European Appln. No. 19172980.5 mailed Apr. 30, 2024.Applicant
- Moisa. Copending U.S. Appl. No. 18/672,596, filed May 23, 2024 (a copy is not yet available to the public and the Examiner has ready access to the cited application).Applicant
- Moisa. Copending U.S. Appl. No. 18/672,734, filed May 23, 2024 (a copy is not yet available to the public and the Examiner has ready access to the cited application).Applicant
- Extended European Search Report issued in European Appln. No. 19172980.5 mailed Aug. 21, 2019.Applicant
- Notice of Allowance issued in U.S. Appl. No. 15/254,130 mailed Sep. 12, 2019.Applicant
- Notice of Allowance issued in U.S. Appl. No. 15/663,077 mailed Sep. 24, 2019.Applicant
- Office Action issued in German Patent Appln. No. 112008003108.8 mailed Oct. 28, 2019. English machine translation provided.Applicant
- Extended European Search Report issued in European Application No. 19189222.3 mailed Nov. 29, 2019.Applicant
- Office Action issued in U.S. Appl. No. 15/784,722 mailed Mar. 23, 2020.Applicant
- Office Action issued in U.S. Appl. No. 15/784,775 mailed Mar. 23, 2020.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 16/655,775 on Nov. 1, 2019.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 16/658,820 on Nov. 7, 2019.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 16/662,537 on Nov. 19, 2019.Applicant
- Extended European Search Report issued in European Application No. 19215957.2 mailed Mar. 26, 2020.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 16/369,528 on May 12, 2022.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 16/381,317 on May 16, 2022.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 16/381,344 on May 16, 2022.Applicant
- Copending U.S. Appl. No. 17/716,303, filed Apr. 8, 2022 (a copy is not yet available to the public and the Examiner has ready access to the cited application).Applicant
- Amendment filed in copending U.S. Appl. No. 17/500,186 on Apr. 28, 2022.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 17/500,186 on May 18, 2022.Applicant
- Non-Final Office Action issued in copending U.S. Appl. No. 16/369,528 mailed Dec. 6, 2021.Applicant
- Notice of Allowance issued in Chinese Application No. 201810941271.5 mailed Dec. 22, 2021.Applicant
- Non-Final Office Action issued in copending U.S. Appl. No. 16/381,317 mailed Jan. 10, 2022.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 16/521,712 mailed Jan. 11, 2022.Applicant
- Amendment filed in copending U.S. Appl. No. 16/658,820 on Jan. 17, 2022.Applicant
- Amendment filed in copending U.S. Appl. No. 16/662,537 on Jan. 18, 2022.Applicant
- Non-Final Office Action issued in copending U.S. Appl. No. 16/381,344 mailed Feb. 1, 2022.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 17/584,705 on Feb. 2, 2022.Applicant
- Copending U.S. Appl. No. 17/584,705, filed Jan. 26, 2022 (a copy is not yet available to the public and the Examiner has ready access to the cited application).Applicant
- Non-Final Office Action issued in copending U.S. Appl. No. 17/500,186 mailed Feb. 9, 2022.Applicant
- Amendment filed in copending U.S. Appl. No. 15/299,640 on Feb. 8, 2022.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 16/662,537 mailed Feb. 14, 2022.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 16/161,319 mailed Feb. 16, 2022.Applicant
- Office Action issued in copending European Application No. 19172980.5 mailed Jan. 21, 2022.Applicant
- Becker R. et al., “Ablation of Atrial Fibrillation: Energy Sources and Navigation Tools: A Review”, Journal of Electrocardiology, 37 (Supplement 2004): 55-62, 2004.Applicant
- Calkins, Hugh, “Radiofrequency Catheter Ablation of Supraventricular Arrhythmias”, Heart, 85:594-600, 2001.Applicant
- De Ponti et al., “Non-Fluoroscopic Mapping Systems for Electrophysiology: The ‘Tool or Toy’ Dilemma After 10 Years”, European Heart Journal 27:1134-1136, 2006.Applicant
- Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Office Action dated Dec. 13, 2013; Notice of Allowance dated Jul. 25, 2014 for U.S. Appl. No. 11/475,950, 19 pgs.Applicant
- Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Office Action dated Jan. 3, 2012; Office Action dated Apr. 3, 2014; Notice of Allowance dated Aug. 26, 2014 for U.S. Appl. No. 11/941,819, 35 pgs.Applicant
- Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Amendment filed Apr. 10, 2014; Supplemental Amendment filed Feb. 12, 2013 for U.S. Appl. No. 11/475,950, 21 pgs.Applicant
- Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Preliminary Amendment filed Aug. 22, 2014; Preliminary Amendment filed Mar. 5, 2013 for U.S. Appl. No. 13/785,910, 10 pgs.Applicant
- Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Preliminary Amendment filed Aug. 22, 2014; Preliminary Amendment filed Mar. 5, 2013 for U.S. Appl. No. 13/785,931, 10 pgs.Applicant
- Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Preliminary Amendment filed Oct. 22, 2013 for U.S. Appl. No. 13/942,354, 13 pgs.Applicant
- Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Preliminary Amendment filed Aug. 20, 2014 for U.S. Appl. No. 13/782,889, 11 pgs.Applicant
- Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Preliminary Amendment filed Mar. 14, 2013 for U.S. Appl. No. 13/782,867, 8 pgs.Applicant
- Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Amendment filed Jul. 3, 2014; Amendment filed Apr. 2, 2012; Amendment filed Mar. 1, 2012; Amendment filed Nov. 23, 2011; Replacement drawings filed Feb. 13, 2008 for U.S. Appl. No. 11/941,819, 78 pgs.Applicant
- Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Preliminary Amendment filed May 12, 2014; Preliminary Amendment filed May 2, 2014 for U.S. Appl. No. 14/229,305, 12 pgs.Applicant
- Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Preliminary Amendment filed May 12, 2014; Preliminary Amendment filed May 2, 2014 for U.S. Appl. No. 14/229,250, 10 pgs.Applicant
- Gelbart et al., Medical Device for Use in Bodily Lumens, for Example an Atrium, Amendment filed Sep. 22, 2014, for U.S. Appl. No. 13/070,215, 18 pgs.Applicant
- Gelbart et al., Medical Device for Use in Bodily Lumens, for Example an Atrium, Office Action dated Jun. 20, 2014, for U.S. Appl. No. 13/070,215, 8 pgs.Applicant
- Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Supplemental Notice of Allowance dated Oct. 6, 2014 for U.S. Appl. No. 11/941,819, 4 pgs.Applicant
- Notice of Allowance issued in U.S. Appl. No. 13/793,213 mailed Aug. 10, 2016.Applicant
- Non-Final Office Action issued in U.S. Appl. No. 13/942,354 mailed Aug. 4, 2016.Applicant
- Notice of Allowance issued in U.S. Appl. No. 14/136,946 mailed May 12, 2016.Applicant
- Notice of Allowance issued in U.S. Appl. No. 13/782,867 mailed Aug. 12, 2016.Applicant
- Notice of Allowance issued in U.S. Appl. No. 13/782,903 mailed Jul. 6, 2016.Applicant
- Corrected Notice of Allowance issued in U.S. Appl. No. 13/782,903 mailed Jul. 19, 2016.Applicant
- Non-Final Office Action issued in U.S. Appl. No. 14/229,305, mailed Apr. 29, 2016.Applicant
- Notice of Allowance issued in U.S. Appl. No. 29/509,621, mailed Sep. 27, 2016.Applicant
- Notice of Allowance issued in U.S. Appl. No. 29/509,636, mailed Sep. 27, 2016.Applicant
- Office Action issued in Chinese Application No. 201510432392.3 mailed May 18, 2018. Concise Explanation of Relevance provided.Applicant
- Amendment filed in U.S. Appl. No. 14/564,463 on Oct. 17, 2017.Applicant
- Notice of Allowance issued in U.S. Appl. No. 14/713,114 mailed Nov. 1, 2017.Applicant
- Notice of Allowance issued in U.S. Appl. No. 14/564,463 mailed Nov. 9, 2017.Applicant
- Preliminary Amendment filed in U.S. Appl. No. 15/784,555 on Nov. 7, 2017.Applicant
- Preliminary Amendment filed in U.S. Appl. No. 15/784,775 on Nov. 7, 2017.Applicant
- Preliminary Amendment filed in U.S. Appl. No. 15/784,722 on Nov. 7, 2017.Applicant
- Preliminary Amendment filed in U.S. Appl. No. 15/725,731 on Oct. 24, 2017.Applicant
- Preliminary Amendment filed in U.S. Appl. No. 15/784,647 on Nov. 7, 2017.Applicant
- Preliminary Amendment filed in U.S. Appl. No. 15/725,662 on Oct. 24, 2017.Applicant
- Office Action issued in U.S. Appl. No. 14/804,924 mailed Nov. 17, 2017.Applicant
- Response to Office Action filed in U.S. Appl. No. 13/785,910 on Nov. 30, 2017.Applicant
- Amendment filed in U.S. Appl. No. 13/785,910 on Feb. 27, 2018.Applicant
- Examination Report issued in European Application No. 13793216.6 mailed Nov. 24, 2017.Applicant
- Office Action issued in Chinese Application No. 201510432392.3 mailed Nov. 17, 2017. Concise Explanation of Relevance and English translation provided.Applicant
- Examination Report issued in European Application No. 15188407.9 mailed Dec. 11, 2017.Applicant
- Office Action issued in U.S. Appl. No. 13/785,910 mailed Jan. 12, 2018.Applicant
- Amendment filed in U.S. Appl. No. 14/804,924 on Feb. 27, 2018.Applicant
- Office Action issued in U.S. Appl. No. 14/804,810 mailed Nov. 30, 2017.Applicant
- Amendment filed in U.S. Appl. No. 14/804,810 on Feb. 27, 2018.Applicant
- Notice of Allowance issued in U.S. Appl. No. 14/804,924 mailed Mar. 27, 2018.Applicant
- Notice of Allowance issued in U.S. Appl. No. 14/804,810 mailed Mar. 30, 2018.Applicant
- Buchbinder, Maurice MD, “Dynamic Mitral Valve Annuloplasty: A Reshapable Ring for Residual and Recurring MR,” from the Foundation for Cardiovascular Medicine, La Jolla, CA. May 24, 2007.Applicant
- Gabriel et al., “The Dielectric Properties of Biological Tissues: I. Literature Survey,” Phys. Med. Biol. 41:2231-2249, 1996.Applicant
- Konings et al., “Development of an Intravascular Impedance Catheter for Detection of Fatty Lesions in Arteries,” IEEE Transactions on Medical Imaging, 16(4):439-446, 1997.Applicant
- Mack, “New Techniques for Percutaneous Repair of the Mitral Valve,” Heart Failure Review, 11:259-268, 2006.Applicant
- Otasevic et al., “First-in-Man Implantation of Left Ventricular Partitioning Device in a Patient With Chronic Heart Failure: Twelve-Month Follow-up,” Journal of Cardiac Failure 13(7):517-520, 2007.Applicant
- Sharkey et al., “Left Ventricular Apex Occluder. Description of a Ventricular Partitioning Device,” EuroIntervention 2:125-127, 2006.Applicant
- Stiles, et al., “Simulated Characterization of Atherosclerotic Lesions in the Coronary Arteries by Measurement of Bioimpedance,” IEE Transactions on Biomedical Engineering, 50(7):916-921,2003.Applicant
- Tanaka et al., “Artificial SMA Valve for Treatment of Urinary Incontinence: Upgrading of Valve and Introduction of Transcutaneous Transformer,” Bio-Medical Materials and Engineering 9:97-112, 1999.Applicant
- Timek et al.., “Septal-Lateral Annular Cinching (‘SLAC’) Reduces Mitral Annular Size Without Perturbing Normal Annular Dynamics,” Journal of Heart Valve Disease 11 (1):2-10, 2002.Applicant
- Timek et al., “Septal-Lateral Annular Cinching Abolishes Acute Ischemic Mitral Regurgitation,” Journal of Thoracic and Cardiovascular Surgery, 123(5):881-888, 2002.Applicant
- Valvano et al., “Thermal Conductivity and Diffusivity of Biomaterials Measured with Self-Heated Thermistors,” International Journal of Thermodynamics, 6(3):301-311, 1985.Applicant
- Gelbart et al., “Automatic Atherectomy System,” Office Action mailed Mar. 4, 2009 for U.S. Appl. No. 11/436,584, 7 pages.Applicant
- Gelbart et al., “Automatic Atherectomy System,” Amendment filed Aug. 4, 2009 for U.S. Appl. No. 11/436,584, 35 pages.Applicant
- Gelbart et al., “Automatic Atherectomy System,” Office Action mailed Dec. 1, 2009 for U.S. Appl. No. 11/436,584, 10 pages.Applicant
- Gelbart et al., “Automatic Atherectomy System,” Amendment filed Mar. 30, 2010 for U.S. Appl. No. 11/436,584, 20 pages.Applicant
- Gelbart et al., “Automatic Atherectomy System,” Amendment filed Oct. 25, 2010 for U.S. Appl. No. 11/436,584, 9 pages.Applicant
- Gelbart et al., “Automatic Atherectomy System,” Office Action mailed Dec. 14, 2010 for U.S. Appl. No. 11/436,584, 12 pages.Applicant
- Gelbart et al., “Intra-Cardiac Mapping and Ablation Method,” Preliminary Amendment filed Aug. 29, 2007 for U.S. Appl. No. 11/475,950,42 pages.Applicant
- Gelbart et al., “Intra-Cardiac Mapping and Ablation Method,” Amendment filed Mar. 5, 2008 for U.S. Appl. No. 11/475,950, 11 pages.Applicant
- Gelbart et al., “Intra-Cardiac Mapping and Ablation Method,” Office Action mailed Jun. 23, 2010 for U.S. Appl. No. 11/475,950, 18 pages.Applicant
- Gelbart et al., “Intra-Cardiac Mapping and Ablation Method,” Amendment filed Aug. 16, 2010 for U.S. Appl. No. 11/475,950, 22 pages.Applicant
- Gelbart et al., “Intra-Cardiac Mapping and Ablation Method,” Office Action mailed Nov. 23, 2010 for U.S. Appl. No. 11/475,950, 25 pages.Applicant
- Gelbart et al., “Intra-Cardiac Mapping and Ablation Method,” Amendment filed Feb. 23, 2011 for U.S. Appl. No. 11/475,950, 28 pages.Applicant
- Gelbart et al., “Automatic Atherectomy System,” Office Action mailed Jun. 15, 2011, for U.S. Appl. No. 12/950,871, 16 pages.Applicant
- Gelbart et al., “Liposuction System,” Office Action mailed Mar. 16, 2011 for U.S. Appl. No. 12/010,458, 12 pages.Applicant
- Gelbart et al., “Liposuction System,” Amendment filed Jun. 10, 2011 for U.S. Appl. No. 12/010,458, 10 pages.Applicant
- Lichtenstein “Method and Apparatus for Percutaneous Reduction of Anterior-Posterior Diameter of Mitral Valve,” U.S. Appl. No. 10/690,131, filed Oct. 20, 2003, 31 pages.Applicant
- International Search Report, mailed Dec. 5, 2007, for PCT/US2007/014902, 5 pages.Applicant
- International Preliminary Report on Patentability, issued Jan. 6, 2009, for PCT/US2007/014902, 8 pages.Applicant
- International Search Report, mailed Dec. 2, 2009, for PCT/US2008/083644, 5 pages.Applicant
- Written Opinion, mailed Dec. 5, 2007, for PCT/US2007/014902, 7 pages.Applicant
- Written Opinion, mailed Dec. 2, 2009, for PCT/US2008/083644, 9 pages.Applicant
- Gelbart et al., “Automatic Atherectomy System,” Amendment filed Sep. 15, 2011 for U.S. Appl. No. 12/950,871, 21 pages.Applicant
- Gelbart et al., “Liposuction System, ” Amendment filed Dec. 7, 2011 for U.S. Appl. No. 12/010,458, 15 pages.Applicant
- Gelbart et al., “Liposuction System,” Office Action mailed Sep. 14, 2011 for U.S. Appl. No. 12/010,458, 9 pages.Applicant
- Notice of Allowance issued in U.S. Appl. No. 13/782,889, mailed Aug. 25, 2016.Applicant
- Office Action issued in U.S. Appl. No. 14/564,463 mailed Feb. 28, 2017.Applicant
- Notice of Allowance issued in U.S. Appl. No. 13/942,354 mailed Feb. 10, 2017.Applicant
- Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Amendment filed in co-pending U.S. Appl. No. 13/785,910 on Mar. 24, 2017, 30 pgs.Applicant
- Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Amendment filed in co-pending U.S. Appl. No. 14/521,692 on Mar. 31, 2017, 9 pgs.Applicant
- Office Action issued in Chinese Patent Application No. 201510432392.3 mailed Mar. 8, 2017. English concise Explanation of Relevance provided.Applicant
- Decision to Refuse a European Patent Application issued in European Patent Application No. 13172848.7 mailed Feb. 22, 2017.Applicant
- Notice of Allowance issued in U.S. Appl. No. 14/521,692 mailed May 19, 2017.Applicant
- Office Action issued in U.S. Appl. No. 14/713,114 mailed Jun. 1, 2017.Applicant
- Quayle Action issued in U.S. Appl. No. 14/713,190 mailed May 30, 2017.Applicant
- Office Action issued in German Application No. 112008003108.8 mailed May 8, 2017. English translation provided.Applicant
- Amendment filed in U.S. Appl. No. 14/564,463, filed May 25, 2017.Applicant
- Office Action issued in U.S. Appl. No. 14/564,463 mailed Jul. 17, 2017.Applicant
- European Search Report issued in European Appln. No. 14871405.8 mailed Jul. 5, 2017.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 15/299,640 pp. 4 filed Oct. 21, 2016.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 15/299,640 pp. 11 filed Dec. 9, 2016.Applicant
- Response to Quayle Office Action filed in U.S. Appl. No. 14/713,190 filed Jul. 24, 2017.Applicant
- Preliminary Amendment filed in U.S. Appl. No. 14/521,692, filed Oct. 23, 2014.Applicant
- Office Action issued in U.S. Appl. No. 13/785,910 mailed Aug. 30, 2017.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 15/663,077 on Aug. 8, 2017.Applicant
- Amendment filed in U.S. Appl. No. 14/713,114, filed Aug. 23, 2017.Applicant
- Notice of Allowance issued in U.S. Appl. No. 14/713,190 mailed Aug. 28, 2017.Applicant
- Office Action issued in Chinese Application No. 201810941271.5 mailed Jun. 3, 2021. English language Statement of Relevance provided.Applicant
- Amendment filed in copending U.S. Appl. No. 15/287,988 on Jul. 28, 2021.Applicant
- Non-Final Office Action issued in copending U.S. Appl. No. 16/521,712 on Sep. 30, 2021.Applicant
- Copending U.S. Appl. No. 17/500,186 filed on Oct. 13, 2021 (a copy is not yet available to the public and the Examiner has ready access to the cited application).Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 17/500,186 filed on Oct. 19, 2021.Applicant
- Non-Final Office Action issued in copending U.S. Appl. No. 16/658,820 on Oct. 22, 2021.Applicant
- Office Action issued in U.S. Appl. No. 15/697,744 mailed Feb. 28, 2020.Applicant
- Office Action issued in U.S. Appl. No. 15/784,647 mailed Feb. 28, 2020.Applicant
- Office Action issued in U.S. Appl. No. 15/784,555 mailed Mar. 9, 2020.Applicant
- Office Action issued in U.S. Appl. No. 15/725,662 mailed on May 13, 2020.Applicant
- Office Action issued in U.S. Appl. No. 15/725,731 mailed on May 15, 2020.Applicant
- Amendment filed in U.S. Appl. No. 15/784,647 on May 27, 2020.Applicant
- Amendment filed in U.S. Appl. No. 15/697,744 on May 27, 2020.Applicant
- Amendment filed in U.S. Appl. No. 15/784,555 on Jun. 3, 2020.Applicant
- Examination Report issued in Indian Application No. 9902/DELNP/2014 mailed on Jun. 19, 2020. English translation provided.Applicant
- Office Action issued in U.S. Appl. No. 15/697,744 mailed on Jul. 8, 2020.Applicant
- Amendment and Statement on the Substance of the Interview filed in U.S. Appl. No. 15/784,722 on Jul. 9, 2020.Applicant
- Amendment and Statement on the Substance of the Interview filed in U.S. Appl. No. 15/784,775 on Jul. 9, 2020.Applicant
- Notice of Allowance issued in U.S. Appl. No. 15/784,647 mailed on Jul. 23, 2020.Applicant
- Bard, “Mesh Ablator Catheter”, Brochure, 2008, 4 pgs, Bard Electrophysiology Division, C.R. Bard Inc., 55 Technology Drive Lowell, MA 07851 USA.Applicant
- Biotronik's “AICath Flutter Gold Cath for Atrial Flutter Available in EU”, Sep. 19, 2013, medGadget, 3 pgs, http://www.medgadget.com/2013/09/biotroniks-alcath-flutter-gold-cath-for-atrial-flutter-unveiled-in-europe.html [Jun. 24, 2014 2:37:09 PM].Applicant
- “Constellation Mapping Catheters”, Brochure, Boston Scientific Corp., 2 pgs © 2007 Boston Scientific Corporation.Applicant
- “Waveforms and Segments”, Ensite System Instructions for use, 54-06154-001 Rev02, Chapter 7 pp. 85-90 © 2007 St. Jude Medical.Applicant
- Extended European Search Report and EP search opinion for EP 12736677.1, mail date Mar. 28, 2014, corresponding to PCT/US2012/022061.Applicant
- Extended European Search Report and EP search opinion for EP 12736962.7, mail date Mar. 28, 2014, corresponding to PCT/US2012/022062.Applicant
- Extended European Search Report mailed Aug. 20, 2013 issued in EP Patent Application No. 13172848.7.Applicant
- Written Opinion dated Aug. 22, 2012 for PCT/US2012/022061, 6 pgs.Applicant
- International Search Report and Written Opinion mailed Aug. 2, 2013 issued in PCT/CA2013/050350.Applicant
- International Search Report and Written Opinion mailed Sep. 17, 2013 issued in PCT/US2013/039982.Applicant
- International Search Report and Written Opinion mailed Sep. 27, 2013 issued in PCT/US2013/039977.Applicant
- International Search Report dated Jul. 30, 2012 for PCT/US2012/022062, 5 pgs.Applicant
- Written Opinion dated Jul. 30, 2012 for PCT/US2012/022062, 5 pgs.Applicant
- International Search Report dated Aug. 22, 2012 for PCT/US2012/022061, 5 pgs.Applicant
- “Phased RF Catheter Ablation System”, 2014 Medtronic Inc., 2 pgs, http://www.medtronic.eu/your-health/atrial-fibrillation/about-the-therapy/our-phased-rf-ablation-system/[Jun. 24, 2014 2:38:05 PM].Applicant
- “ThermoCool® Irrigated Tip Catheter”, Brochure, Biosense Webster, 4 pgs , Biosense Webster, Inc. 3333 Diamond Canyon Road Diamond Bar, CA 91765, USA, © Biosense Webster, Inc. 2009 All rights reserved. 1109003.0.Applicant
- Gelbart “Medical Device for Use in Bodily Lumens, for Example an Atrium”, OA mailed Jul. 25, 2011 for U.S. Appl. No. 11/941,819, now published as US 2009-0131930 A1.Applicant
- Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Notice of Allowance dated Oct. 23, 2014 for U.S. Appl. No. 11/475,950, 10 pgs.Applicant
- Gelbart et al., “Medical Device for Use in Bodily Lumens, for Example an Atrium”, Notice of Allowance mailed Nov. 13, 2014 for U.S. Appl. No. 13/070,215, 54 pages.Applicant
- International Search Report mailed Mar. 10, 2015, for International Application PCT/CA2014/051144; 10 pages.Applicant
- Written Opinion mailed Mar. 10, 2015, for International Application PCT/CA2014/051144; 4 pages.Applicant
- Official Action issued in CN201280004400.9, mailed Dec. 3, 2014.Applicant
- Non-final Office Action issued in U.S. Appl. No. 13/782,867, dated Apr. 15, 2015.Applicant
- Non-final Office Action issued in U.S. Appl. No. 13/782,903, dated Apr. 28, 2015.Applicant
- Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Office Action mailed May 22, 2015 for U.S. Appl. No. 13/782,889, 86 pages.Applicant
- Lopes et al., “High-Density Electrode-Based Medical Device System”, Office Action mailed Jul. 10, 2015 for U.S. Appl. No. 13/793,076, 98 pages.Applicant
- Lopes et al., “High-Density Electrode-Based Medical Device System”, Office Action mailed Jul. 9, 2015 for U.S. Appl. No. 13/793,213, 99 pages.Applicant
- Gelbart et al., “Apparatus and Method for Intra-Cardiac Mapping and Ablation”, Office Action mailed Aug. 5, 2015 for U.S. Appl. No. 13/785,910, 79 pages.Applicant
- Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Amendment filed Aug. 24, 2015 for U.S. Appl. No. 13/782,889, 21 pages.Applicant
- Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Amendment filed Aug. 28, 2015 for U.S. Appl. No. 13/782,903, 19 pages.Applicant
- Lopes et al., “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Amendment filed Sep. 14, 2015 for U.S. Appl. No. 13/782,867, 25 pages.Applicant
- Lopes et al., “High-Density Electrode-Based Medical Device System”, Amendment filed Oct. 9, 2015 for U.S. Appl. No. 13/793,213, 26 pages.Applicant
- Lopes et al., “High-Density Electrode-Based Medical Device System”, Amendment filed Oct. 9, 2015 for U.S. Appl. No. 13/793,076, 14 pages.Applicant
- Examination Report issued in EP13172848.7, mailed Sep. 21, 2015.Applicant
- Extended European Search Report issued in EP13793216.6, mailed Oct. 30, 2015.Applicant
- Moisa et al., “Catheter System ”, Office Action mailed Nov. 16, 2015 for U.S. Appl. No. 14/136,946, 92 pages.Applicant
- Office Action issued in U.S. Appl. No. 13/782,889, mailed Dec. 18, 2015.Applicant
- Office Action issued in U.S. Appl. No. 13/782,903, mailed Dec. 18, 2015.Applicant
- Extended European Search Report issued in EP15188407.9, mailed Jan. 21, 2016.Applicant
- Lopes et al. “Enhanced Medical Device for Use in Bodily Cavities, for Example an Atrium”, Office Action mailed Jan. 25, 2016 for U.S. Appl. No. 13/782,867, 49 pages.Applicant
- Notice of Allowance issued in U.S. Appl. No. 13/793,076, dated Feb. 10, 2016.Applicant
- Final Office Action issued in U.S. Appl. No. 13/793,213, dated Feb. 26, 2016.Applicant
- Non-Final Office Action issued in U.S. Appl. No. 29/509,719, dated Feb. 25, 2016.Applicant
- Quayle Action issued in U.S. Appl. No. 29/509,621, dated Feb. 26, 2016.Applicant
- Quayle Action issued in U.S. Appl. No. 29/509,636, dated Feb. 26, 2016.Applicant
- Non-Final Office Action issued in U.S. Appl. No. 13/785,910 mailed Apr. 8, 2016.Applicant
- Non-Final Office Action issued in U.S. Appl. No. 14/229,250 mailed Apr. 28, 2016.Applicant
- Notice of Allowance issued in U.S. Appl. No. 13/793,076 mailed Jul. 7, 2016.Applicant
- Summons to Attend Oral Proceedings issued in European Appln. No. 13172848.7, mailed Sep. 1, 2016.Applicant
- Amendment filed in copending U.S. Appl. No. 16/521,732 on Aug. 26, 2022.Applicant
- Amendment filed in copending U.S. Appl. No. 16/521,745 on Aug. 18, 2022.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 16/521,732 mailed Nov. 8, 2022.Applicant
- Office Action issued in copending U.S. Appl. No. 16/995,159 mailed Nov. 15, 2022.Applicant
- Office Action issued in copending U.S. Appl. No. 16/995,222 mailed Nov. 17, 2022.Applicant
- Examination Report issued in European Appln. No. 14871405.8 mailed Jul. 6, 2018.Applicant
- Office Action issued in U.S. Appl. No. 13/785,910 mailed Jun. 15, 2018.Applicant
- Notice of Allowance issued in U.S. Appl. No. 15/784,775 mailed on Aug. 7, 2020.Applicant
- Notice of Allowance issued in U.S. Appl. No. 15/784,555 mailed on Aug. 11, 2020.Applicant
- Amendment and Statement on the Substance of the Interview filed in U.S. Appl. No. 15/725,662 on Aug. 13, 2020.Applicant
- Amendment and Statement on the Substance of the Interview filed in U.S. Appl. No. 15/725,731 on Aug. 13, 2020.Applicant
- Notice of Allowance issued in U.S. Appl. No. 15/784,722 mailed Aug. 14, 2020.Applicant
- Office Action issued in U.S. Appl. No. 16/407,379 on Dec. 24, 2020.Applicant
- Amendment filed in U.S. Appl. No. 16/407,379 on Mar. 23, 2021.Applicant
- Notice of Allowance issued in U.S. Appl. No. 15/725,662 on Sep. 3, 2020.Applicant
- Notice of Allowance issued in U.S. Appl. No. 15/725,731 on Sep. 3, 2020.Applicant
- Notice of Allowance issued in U.S. Appl. No. 15/697,744 on Sep. 18, 2020.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 16/995,159 on Sep. 25, 2020.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 16/995,222 on Sep. 25, 2020.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 17/182,732 on Mar. 11, 2021.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 17/072,262 on Dec. 1, 2020.Applicant
- Office Action issued in Chinese Appln. No. 201810941271.5 mailed Nov. 3, 2020. English translation provided.Applicant
- Response to Examination Opinion filed Mar. 18, 2021 for Chinese Patent Application No. 201810941271.5.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 17/182,732 on Feb. 23, 2021.Applicant
- Notice of Allowance issued in U.S. Appl. No. 16/407,379 on Apr. 1, 2021.Applicant
- Office Action issued in copending U.S. Appl. No. 15/287,988 mailed May 5, 2021.Applicant
- Supplemental Amendment filed in copending U.S. Appl. No. 15/299,640 on Mar. 1, 2022.Applicant
- Amendment filed in copending U.S. Appl. No. 16/369,528 on Mar. 2, 2022.Applicant
- Notice of Allowance issued in copending U.S. Appl. No. 16/658,820 mailed Mar. 11, 2022.Applicant
- Non-Final Office Action issued in copending U.S. Appl. No. 17/584,705 mailed Mar. 29, 2022.Applicant
- Amendment filed in copending U.S. Appl. No. 16/381,317 on Apr. 4, 2022.Applicant
- Amendment filed in copending U.S. Appl. No. 16/381,344 on Apr. 4, 2022.Applicant
- Communication pursuant to Article 94(3) EPC issued in European Appln. No. 19189222.3 mailed on Nov. 17, 2022.Applicant
- Non-Final Office Action issued in copending U.S. Appl. No. 17/072,262 mailed on Dec. 1, 2022.Applicant
- Final Office Action issued in copending U.S. Appl. No. 16/521,745 mailed on Dec. 9, 2022.Applicant
- Response After Final Action filed in copending U.S. Appl. No. 16/521,745 on Jan. 13, 2023.Applicant
- Amendment filed in U.S. Appl. No. 17/182,732 on Jul. 30, 2024.Applicant
- Notice of Allowance issued in U.S. Appl. No. 17/182,732 mailed Aug. 19, 2024.Applicant
- Lopes. Copending U.S. Appl. No. 18/951,919, filed Nov. 19, 2024 (a copy is not yet available to the public and the Examiner has ready access to the cited application).Applicant
- Communication under Rule 71(3) EPC issued in European Appln. No. 19172980.5 mailed Oct. 2, 2024.Applicant
- Office Action issued in copending U.S. Appl. No. 18/543,175 mailed Dec. 2, 2024.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 18/951,919 on Nov. 19, 2024.Applicant
- Second Preliminary Amendment filed in copending U.S. Appl. No. 18/951,919 on Jan. 7, 2025.Applicant
- Lopes. Copending U.S. Appl. No. 19/016,030, filed Jan. 10, 2025 (a copy is not yet available to the public and the Examiner has ready access to the cited application).Applicant
- Lopes. Copending U.S. Appl. No. 19/016,112, filed Jan. 10, 2025 (a copy is not yet available to the public and the Examiner has ready access to the cited application).Applicant
- Amendment filed in copending U.S. Appl. No. 18/543,175 on Jan. 8, 2025.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 19/016,030 on Jan. 10, 2025.Applicant
- Preliminary Amendment filed in copending U.S. Appl. No. 19/016,112 on Jan. 10, 2025.Applicant
- Second Preliminary Amendment filed in copending U.S. Appl. No. 19/016,030 on Jan. 17, 2025.Applicant
- Second Preliminary Amendment filed in copending U.S. Appl. No. 19/016,112 on Jan. 17, 2025.Applicant
- Supplemental Amendment filed in copending U.S. Appl. No. 18/543,175 on Jan. 23, 2025.Applicant
- Final Office Action issued in copending U.S. Appl. No. 18/543,175 mailed Feb. 19, 2025.Applicant
- Non-Final Office Action issued in U.S. Appl. No. 19/016,030 mailed Mar. 11, 2025.Applicant
- Non-Final Office Action issued in U.S. Appl. No. 19/016,112 mailed Mar. 11, 2025.Applicant
- Communication Under Rule 71(3) EPC issued in European Appln. No. 19189222.3 mailed Mar. 13, 2025.Applicant
- Response filed in U.S. Appl. No. 19/016,112 on May 5, 2025.Applicant
- Notice of Allowance issued in U.S. Appl. No. 19/016,112 mailed May 20, 2025.Applicant
- Response filed in U.S. Appl. No. 19/016,030 on May 30, 2025.Applicant
- Notice of Allowance issued in U.S. Appl. No. 19/016,030 mailed Jun. 24, 2025.Applicant
- Notice of Allowance issued in U.S. Appl. No. 18/543,175 mailed Aug. 14, 2025.Applicant
- Amendment Submitted with Request for Continued Examination filed in U.S. Appl. No. 18/543,175 on Jul. 31, 2025.Applicant
- Extended European Search Report issued in European Appln. No. 25196433.4 mailed Oct. 8, 2025.Applicant
- Lopes. Copending U.S. Appl. No. 19/394,340, filed Nov. 19, 2025 (a copy is not yet available to the public and the Examiner has ready access to the cited application).Applicant